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ABSTRACT 
Jessica Nesmith: Investigation of Flt1 and VEGF signaling in connections during sprouting 
angiogenesis 
(Under the Direction of Victoria L. Bautch) 
 
Blood vessel formation is essential for vertebrate development and is primarily achieved by 
angiogenesis, the sprouting of endothelial cells from pre-existing vessels. Vessel networks 
expand when sprouts form new connections, a process whose regulation is poorly understood. 
Here we show that vessel anastomosis is spatially regulated by VEGFR1 (Flt1), a VEGF-A 
receptor that acts as a ligand decoy. Expanding vessel networks in vivo favor interactions with 
flt-1 mutant endothelial cells. Live imaging in vitro revealed that stable connections are preceded 
by transient contacts from extending sprouts, suggesting sampling of potential target sites, and 
reduction of Flt1 reduced transient contacts. Endothelial cells at target sites with elevated 
protrusive activity and/or reduced Flt1 were more likely to form stable connections with 
incoming sprouts. Target cells with reduced membrane-localized Flt1 (mFlt1), but not soluble 
Flt1, recapitulated the bias towards stable connections, suggesting that relative mFlt1 expression 
spatially influences selection of stable connections. Thus multiple sprout anastomosis parameters 
are regulated by VEGF signaling, and stable connections are spatially regulated by endothelial 
cell-intrinsic modulation of mFlt1, suggesting new ways to manipulate how vessel networks 
form.  
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CHAPTER 1: Introduction 
 
The body of work presented here seeks to understand the impact of regulatory signaling on 
the formation of a complex, structured blood vessel network. There are a large number of growth 
factors implicated in the process; however, the vascular endothelial growth factor ligand family 
is a major main growth factor implicated in directing blood vessel growth and the focus of these 
studies. Blood vessel expansion into a hierarchical network of arteries and veins connected by 
capillaries is accomplished through angiogenesis. The varying interactions and interplay of 
signaling cascades that direct the initiation and coordinated migration of angiogenesis is highly 
researched but these same cascades are not evaluated during anastomosis, the process of two 
vessel connecting. Therefore, this work addresses the regulation anastomosis of sprouting 
angiogenesis through spatio-temporal restriction of growth factor signaling. 
 
 
I. Angiogenic blood vessel network formation during development 
Blood vessels comprise the vascular network and carry oxygen and nutrients within blood 
and plasma throughout the body in addition to being the primary route of metabolic waste 
transport. As such, appropriate vascularization of tissues is a critical and highly regulated 
process. The formation of a branched vascular network is an essential, conserved process in 
vertebrates. The vascular system is the first organ to develop in the vertebrate embryo, and is 
functional and carrying blood by 24 hours post-fertilization (hpf) in zebrafish and as early as 
embryonic day 8 (E8.0) in mice (Drake & Fleming 2000; Isogai et al. 2001). In addition to 
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forming early, the vascular system is also necessary for continued development. Zebrafish 
embryos with mutations which cause defective heart muscle, can survive for 5 days post-
fertilization (dpf) without a functioning circulatory system using passive oxygen diffusion from 
the water, but subsequent development requires cardiovascular function (J. N. Chen et al. 1996). 
Similarly, mouse embryos cannot survive past E9.5 without a functional circulatory system, as is 
observed in various genetic mutants which fail to form blood vessels (Carmeliet et al. 1996; 
Ferrara et al. 1996). Thus, in diverse vertebrate lineages embryonic survival and appropriate 
development relies upon the formation and expansion of an effective vascular network. 
Blood vessel development during embryogenesis is a multistep process that begins with 
primitive vessel formation from endothelial progenitor cells (EPCs) through a process known as 
vasculogenesis (Risau & Flamme 1995; Drake & Fleming 2000). Vasculogenesis creates the 
large, primary arteries and veins within the embryo and generates the initial vessel network. 
Blood vessels are composed of multiple cell types: 1) the endothelium is composed of 
endothelial cells (EC) that line the luminal side of the vessel; and 2) support cells, including 
pericytes and the smooth muscle cells of arteries that constrict to pump blood. The initial EPC 
undergo directed migration and coalesce into a cord that is then remodeled into a tubular 
structure which later becomes a lumenized vessel (Xu & Cleaver 2011). The vessels that form 
the initial arteries and veins carry blood throughout the developing embryo.  
As the embryo grows a larger and more complex vessel network is needed. Angiogenesis forms 
the branched, hierarchical vessel networks, comprising capillary beds connecting the arteries and 
veins that are present throughout life. The expansion and increased complexity of the developing 
vessel network is driven through sprouting angiogenesis. The de novo creation and subsequent 
expansion of the vascular system is directed through a multitude of growth factors and signaling 
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pathways. The primary growth factor implicated in both processes is vascular endothelial growth 
factor (VEGF) ligand family. VEGF was first described as vascular permeability factor (VPF) 
and is a secreted protein first identified by its ability to increase vessel density and permeability 
in tumors and upon exogenous expression (Folkman et al. 1971; Senger et al. 1983). Since its 
initial description and cloning (Senger et al. 1983; Leung et al. 1989; Ferrara & Henzel 1989), an 
extensive body of research has investigated the VEGF ligand family and signaling.  
 
II. VEGF signal propagation and ligand specific effects 
The VEGF ligand family induces responses in the endothelium that are complex and 
influenced by a variety of factors, including ligand identity and cofactors. There are 4 known 
VEGF ligands in the endothelial cells, VEGFA-D, that are differentially expressed and bind with 
varying affinities to three tyrosine kinase receptors (VEGFR1-3) (Lohela et al. 2009).  
In regards to EC, VEGF-A ligand binds to two tyrosine kinase receptors, Flk1 
(KDR/VEGFR2) and Flt1 (VEGFR1) which initiate and dampen its signaling cascade, 
respectively (de Vries et al. 1992; Terman et al. 1992; Quinn et al. 1993). Downstream of ligand-
receptor binding, tyrosine phosphorylation of Flk1 initiates a host of signaling cascades, which 
eventually result in increased migration, increased proliferation, and blockade of apoptosis 
(Holmqvist et al. 2004; Takahashi et al. 2001). Increasing levels of VEGF-A ligand causes 
activation of EC, leading to angiogenesis (Gerhardt et al. 2003; Kappas et al. 2008). These 
receptors and their roles in developmental angiogenesis, along with the role of the VEGF ligands 
during development are discussed in more detail below.  
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a. Flk1 during developmental angiogenesis 
Flk1 contains a conserved selective binding domain for the VEGF family of ligands, and is 
capable of binding VEGF-A with a Kd of 750 pM (Terman et al. 1992; Quinn et al. 1993; 
Shinkai et al. 1998). Flk1 bound to VEGF-A triggers mitogenic signaling that increases EC 
proliferation, chemotaxis, and promotes cell survival; thereby initiating and sustaining 
sprouting angiogenesis (Koch et al. 2011).  
To understand the role Flk1 plays within EC of growing vessels, mechanistic studies 
investigating the main phosphorylation sites that trigger signaling were mapped. The four main 
tyrosine/Tyr/Y phosphorylation sites on Flk1 were found to be Y951, Y1054/1059, Y1175, and 
Y1214 (Olsson et al. 2006). The receptor tyrosine kinase activity is initiated through a 
phosphorylation cascade, largely downstream of phospholipase C gamma (PLCγ) and 
phosphoinositide 3-kinase (PI3K). The sites and their effects are summarized in Table 1 and 
explained in further detail below.  
Table 1: Major Phosphorylation Sites of Flk1 and Cellular Effects/Interactions.  
Phosphorylation 
Site 
Signaling 
pathway/s 
activated 
Main cellular 
effects 
Cellular function 
Direct protein 
interactions 
Y951 Src Migration Alters adhesion TSAd 
Y1054/1059   
Propagates 
signaling  
 
Y1175 PLCγ, PI3K 
Proliferation, 
Anti-apoptosis 
Cell division PLCγ, SHB, Sck 
Y1214 p38/MAPK Migration  Motility  Nck 
 
Phosphorylation at Y1054/1059 supports further phosphorylation and thought to occur first and 
propagate signaling through bolstering activity of the other sites (Kendall et al. 1999). This site 
is proposed to alter conformation of the receptor and change the availability or accessibility of 
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the activating phosphorylation sites on the Flk1 receptor. Phosphorylation at Y951 alters cell 
surface localization of VE-Cadherin and cytoskeletal rearrangements that are needed for 
cellular migration through T-cell-specific adapter molecule (TSAd) (Wu et al. 2000; 
Matsumoto et al. 2005; Gavard & Gutkind 2006). This phosphorylation event is therefore 
associated with chemotaxis and an increase in migratory potential. In fact, recent studies 
demonstrated TSAd is directly linked to junction adhesiveness and migration (Gordon et al. 
2016). Phosphorylation at Y1214 also induces migration through activating p38 mitogen-
activated protein kinase (MAPK) when phosphorylated (Lamalice et al. 2004; Lamalice et al. 
2006). Unlike the other two sites, when Y1175 is phosphorylated it recruits and phosphorylates 
PLCγ, which then induces activation of protein kinase C (PKC) to increase the proliferation 
(thereby also blocking apoptosis) (Takahashi et al. 1999; Meadows et al. 2001). Active PKC 
downstream of Flk1 signaling initiates a signaling cascade that is directly linked to and 
increases DNA synthesis (Xia et al. 1996; Takahashi et al. 1999). This signaling serves to 
increase the number of EC, generating new EC that can be used to expand the vessel network. 
Phosphorylated Y1175 can also activate migration through FAK/Cdc42 downstream of PI3K 
signaling and through Src activation (Xia et al. 1996; Wong & Jin 2005; Holmqvist et al. 
2004). The combination of increasing both proliferation and migration results in more cells 
which are motile within the vessel, the two key components to angiogenesis. 
Functional analysis of Flk1 within growing vessels demonstrated specificity to the 
endothelial lineage and an essential role during vessel generation. In vivo genetic deletion of 
Flk1 causes embryonic lethality by day E8.5, with phenotypes that resemble deletion of the 
VEGF-A ligand (Ferrara et al. 1996; Shalaby et al. 1997). Specific mutation of Y1175 to 
F1175 is lethal by E9.5 due to a lack of endothelial and hematopoietic cells, mimicking the 
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receptor deletion phenotype (Sakurai et al. 2005). These two deletion experiments indicate that 
Flk1 is required for proliferation and survival of the endothelium, and support a critical role for 
the Y1175 phosphorylation site. Flk1
-/-
 cells within chimeric mouse embryos, generated with 
Flk1-deficient stem cells, did not contribute to early blood islands which generate the 
hematopoietic lineage or nascent vascular beds; indicating VEGF-A signaling through Flk1 is 
essential for ECs to contribute to the growing vasculature (Shalaby et al. 1997). Similarly, the 
two zebrafish isoforms of Flk1, kdra and kdrb, are both expressed and essential in vessel 
growth (Bahary et al. 2007). Depletion of either kdr in zebrafish embryos using MO injection 
results in angiogenic failure, specifically the intersegmental vessels (ISVs) from the common 
artery do not sprout (Jin et al. 2005; Wiley et al. 2011). In fact, the EC restricted expression of 
this receptor is specific, such that the kdr promoter driving GFP is commonly used as a 
transgenic fish line for visualization of blood vessels from as early as 20 hpf (Lawson & 
Weinstein 2002; Wiley et al. 2011). These in vivo studies demonstrate an intimate link between 
blood vessel growth and VEGF-A signaling through Flk1.  
Binding of VEGF-A to Flk1 causes a series of intracellular signaling events resulting in 
blood vessel growth through angiogenesis. The combined data from biochemical studies and in 
vivo analyses indicate how appropriate activation and regulation of this receptor is essential for 
endothelial growth and quiescence, thus implicating this ligand-receptor cascade in 
anastomosis. Many of the biochemical and vessel morphology effects are described, however 
the precise spatio-temporal influences are less understood. These local and time-dependent 
roles for VEGF-A signaling are likely contributors during anastomosis and warrant closer 
analysis in that context.  
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b. Flt1 during developmental angiogenesis 
VEGFR1/Flt1 was identified as a tyrosine kinase receptor for members of the VEGF ligand 
family. VEGF-A binds to the Flt1 receptor with a Kd of 15 pM, a 10-fold higher affinity than 
Flk1, but exhibits weak kinase activity(Kendall & Thomas 1993; Ito et al. 1998). Additionally, 
Flt1 is expressed as two alternatively spliced isoforms, a membrane-bound tyrosine kinase 
transmembrane receptor (mFlt) and a soluble isoform lacking the transmembrane and tyrosine 
kinase domains (sFlt) (de Vries et al. 1992; Kendall & K. A. Thomas 1993; C. P. Thomas et al. 
2010).  
Flt1 is expressed selectively in the endothelial lineage of mice, both developmentally and 
postnatally (Peters et al. 1993). Complete Flt1 deletion in mice (flt1
-/-
) is embryonic lethal by 
E9.5 due to a poorly organized vasculature and over-proliferation of hemangioblasts over ECs 
(Fong et al. 1995; Fong et al. 1999). Interestingly, inactivation of the tyrosine kinase domain, 
which presumably blocks signaling activity while preserves ligand binding activity, results in a 
developmentally normal mouse; although the mice are more susceptible to pathological 
challenges, including xenograft tumor growth, and have a faster tumor growth and increased 
tumor vessel formation (Hiratsuka et al. 1998; Hiratsuka et al. 2001). Combined, these data 
indicate a reliance on Flt1 for binding VEGF but not as a tyrosine kinase signaling receptor 
during embryonic murine development. Postnatal VEGF-A signaling is essential for patterning 
the retinal vasculature, a well-studied vessel bed due to the stereotyped growth and ease of 
isolation (Gerhardt et al. 2003). Loss of Flt1, either by neutralizing antibody or genetic deletion 
using temporally controlled Cre recombinase expression, increases filopodial extensions and 
tip cells in sprouting retinal vessels (Chappell et al. 2009). These studies conclusively show 
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that despite lacking a strong signaling role during development, Flt1 is required to generate and 
pattern EC to expand the vasculature during both vasculogenesis and angiogenesis in mice. 
In addition to genetic mouse studies, recent work has explored the role of Flt1 in zebrafish 
angiogenesis. Flt1 is expressed in the embryonic fish vasculature, in both the arterial lineage of 
the intersegmental vessels (ISVs) and venous in the caudal vein plexus (CVP) (Krueger et al. 
2011). Analysis of loss-of-function (LOF) and gain-of-function (GOF) manipulations in the 
sub-intestinal vessels (SIVs) demonstrated a regulatory role for Flt1 in angiogenesis. 
Specifically, excess and precocious sprouting was in SIVs without Flt1 and dampened after 
reintroduction of Flt1 by mRNA injection (Avraham-Davidi et al. 2012). LOF MO and GOF 
mRNA injections of VEGF-A and Flt1 also demonstrated that Flt1 influences branching via tip 
cell formation in the ISVs; thus mimicking the phenotypes in the postnatal retinal vessels of 
mice (Chappell et al. 2009; Krueger et al. 2011). Again these data suggest that Flt1 restricts 
angiogenesis, as its deletion results in excess blood vessel growth.  
Finally, previous work from our group examined the role of Flt1 and its isoforms in vitro 
using mouse embryonic stem (ES) cells that undergo endogenously directed differentiation and 
form a multi-cell type bed from which an EC network sprouts and expands (Rylova et al. 
2008). The normal pattern of complex vessel branching is lost and proliferation is increased in 
flt1
-/-
 mouse ES cell-derived vessels (Kearney et al. 2002; Kearney et al. 2004). The 
proliferative effects in vessels are present when either isoform is absent, although the 
branching is largely regulated by sFlt1 within these vessels (Kappas et al. 2008). We recently 
discovered that flt1
-/-
 mouse ES cell-derived vessels show increased sprout initiations 
(Chappell et al. 2016). This finding was in contrast with reduced network complexity found in 
flt1
-/-
 vessels of both ES cell-derived and retinal angiogenic vessels during development 
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(Kappas et al. 2008; Chappell et al. 2009). These discrepant effects were resolved by the fact 
that flt1
-/-
 vessel connections are less stable over time (Chappell et al. 2016). In total, these 
experiments suggest a reliance on Flt1, acting as a VEGF-A ligand sink in sprouting 
angiogenesis, to fine-tune VEGF-A levels during angiogenesis. This role supported by in vivo 
and in vitro studies in model systems. 
Flt1 has been demonstrated to be a ligand-sink for VEGF-A in many contexts, both 
vasculogenic and angiogenic. As the angiogenic and developmental role of the receptor has 
been demonstrated to function outside of its signaling capabilities, the phosphorylation sites 
and signaling cascades, while understood at a basic level (Koch et al. 2011), are not discussed 
here. Rather this receptor is of greater interest for its potential use by the EC to determine local 
levels of VEGF-A signaling, previously hypothesized as a method by which anastomosis is 
directed during angiogenesis.  
c. VEGF ligand effects in animal models 
Genetic deletion of even a single VEGFA allele, vegfa
+/-
, causes embryonic lethality by 
E10.5 in mouse embryos (Carmeliet et al. 1996; Ferrara et al. 1996). VEGFA hemizygous 
embryos exhibit pronounced endothelial apoptosis and compromised vessel integrity, 
characterized by a failure in dorsal aorta closure and decreased EC numbers within the vessels 
of many organ systems (Carmeliet et al. 1996; Ferrara et al. 1996); thus implicating VEGFA in 
the embryonic vascular system. Following the initial characterization of VEGFA in animal 
models, a large body of work has explored the role of VEGF ligands in multiple contexts and 
animal systems. 
VEGF-A ligand can be alternatively spliced into at least nine isoforms, which are classified 
by their molecular weight (Tischer et al. 1991). VEGF-120, VEGF-164, and VEGF-188 are the 
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three most prevalent isoforms in angiogenic vessels and many of their distinct roles in vessel 
growth have been elucidated. Mice genetically engineered to express only VEGF-120 survive 
birth but die by two weeks of age due to cardiorespiratory failure (Carmeliet et al. 1999). Both 
VEGF-164 and VEGF-188 isoform expressing mice survive to fertility, although expression of 
only VEGF-188 exhibits reduced survival and non-Mendelian ratios (Stalmans et al. 2002). 
VEGF-120 and VEGF-188 expressing mice have decreased and disrupted vessel morphology 
in the retinal of postnatal mice, although the VEGF-120 mice show a more severe phenotype 
than the VEGF-188 (Stalmans et al. 2002). Thus, regardless of the isoform, VEGF-A ligand 
interacts with EC to promote vessel growth. In fact, the shared vessel phenotypes in these 
rescue models suggest an overlapping and conserved ability of VEGF-A to regulate ECs. This 
conclusion is supported by parallel experiments in zebrafish that express multiple isoforms of 
VEGF-A, including both VEGF-120 and VEGF-164, within the endothelial lineage of embryos 
as determined by in situ hybridization (Liang et al. 1998; Liang et al. 2001; Bahary et al. 2007). 
Over-expression of either of these isoforms, through mRNA injection, results in excessive 
vessel growth and an increased commitment of cells to the hematopoietic lineage (Liang et al. 
2001). Morpholino (MO) injection to block all VEGF-A ligand causes a decrease in vessels 
throughout the embryo (Nasevicius et al. 2000). Combined, the data from these model systems 
support a conserved role the VEGF-A ligand in appropriate proliferation and health of the 
endothelium.  
Beyond size, these isoforms also vary in their relative abundance and presentation in the 
extracellular matrix (ECM). ECM presentation is critical for binding of VEGFR cofactors and 
modulating signaling strength. Several co-factors that amplify VEGFA signaling have been 
identified, namely heparan sulfate (HS), neuropilins (NRPs) and integrins (Houck et al. 1992; 
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Jakobsson et al. 2006; Kawamura et al. 2008). VEGF-A bound to heparan sulfate in the ECM 
confers the spatial patterning of the blood vessels via ligand sequestration in ECM that 
generates a growth factor gradient to direct angiogenesis (Ruhrberg et al. 2002; Jakobsson et 
al. 2010). Complexing of VEGF-A and Flk1 or Flt1 at the cell surface with NRP-1 promotes 
phosphorylation that augments downstream signaling and increases migration and sprouting of 
endothelial cells (Wang et al. 2003; Pan et al. 2007). Further increases in signal propagation 
are accomplished by αVβ3-integrin, which complex with VEGF-A/Flk1/NRP to amplify the 
signal cascade (Ruhrberg et al. 2002; Robinson et al. 2009). These data demonstrate that 
VEGF-A signaling activity within EC is not only a product of ligand binding at receptors but 
also impacted by the complexing of additional cofactors, an intricate and complicated series of 
binding.  
VEGF-B, VEGF-C, and VEGF-D are structurally similar to VEGF-A but exhibit different 
specificity and binding capacities during development. VEGF-B binds the VEGFR1/Flt1 
receptor and influences heart development, but is developmentally dispensable (Aase et al. 
1999; Bellomo et al. 2000). VEGF-C and VEGF-D are thought to predominately bind 
VEGFR3/Flt4 on hematopoietic cells, specifically regulating formation of the lymphatic 
vessels during lymphangiogenesis (Jeltsch et al. 1997; Schoppmann et al. 2010; Hogan et al. 
2009). The VEGF ligand family as a whole is able to alter signaling within the endothelial 
lineage but VEGF-A, or VEGF within this text, is the primary growth factor implicated in the 
development and maturation of the blood vasculature. 
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III. Sprouting angiogenesis during development 
Sprouting angiogenesis is initiated by mature ECs within established vessels. After exposure 
to new growth factors these EC activate proliferative and migratory programs in order to extend 
processes and initiate a new sprout, followed by migration into the extravascular space along 
guidance cues, then connection or anastomosis with another vessel, and finally create a continual 
luminal space to carry blood flow (Chappell & Bautch 2010). Each of these processes is 
described in more detail below. 
 
a. Sprout initiation from quiescent vessels 
Sprouts form in response to a complex interplay of growth factors within the vascularized 
tissue. The vessels start as stable and quiescent, with the EC contributing to the vessel wall but 
not actively migratory or proliferative, and surrounding by the supportive pericytes and 
macrophages along with the basement membrane. Only upon a change in growth factors in the 
local environment do the EC activate and undergo structural changes. 
A wide array of growth factors have been implicated in sprout initiations, including VEGF, 
Notch, and bone morphogenetic protein (BMP) (Kappas et al. 2008; Wiley et al. 2011; 
Hellström et al. 2007). Notably, EC with low Notch are primed to respond to growth factor 
ligands, such as BMP and VEGF, and contribute to a new sprout while their immediate 
neighboring EC are under the opposite pressure and unresponsive to growth cues (Hellström et 
al. 2007; Mouillesseaux et al. in press). Through lateral inhibition provided by Notch (Benedito 
et al. 2009) cell-by-cell heterogeneity in signaling is amplified through interactive regulation of 
Notch and VEGF-A at the transcriptional level within vessels (Lobov et al. 2007; Wiley et al. 
2011; Suchting et al. 2007), creating inherent differences in the activity and responsiveness of 
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individual ECs. Sprout initiation is a result of the combined effects of these signaling 
pathways, leading to the EC exiting quiescence. Exit from quiescence requires suppression of 
Notch signaling, demonstrated by multiple LOF Notch manipulations in mouse vessels that 
show increased sprout formation (del Toro et al. 2010). For the EC in the sprout to migrate 
away from the parent vessel and into the ECM, the EC loosens established EC-EC junctions, 
alter cellular structures and extends filopodia (Chen et al. 2010; Cruys et al. 2016; Gordon et 
al. 2016; Kushner et al. 2014; Wright et al. 2015), both effects known to occur downstream of 
VEGF-A signaling (Senger et al. 1983; Keck et al. 1989; Dvorak et al. 1995; Taylor et al. 
2010; Zeng & Bautch 2009).  
From these data it becomes apparent that the cumulative growth factor effects within each 
cell contribute to sprout initiation within a vessel. Thus understanding growth factor 
interactions and EC within the context of whole vessels is essential for a complete 
understanding of how these signaling pathways initiate sprouting angiogenesis. Once an 
individual cell has initiated a migratory program and exits the axis of the parent vessel it is a 
part of the new, active sprout.  
b. Sprout migration and extension 
To expand the vessel network, the sprout must migrate away from the parent vessel and 
towards another existing vessel. Cell migration is characterized by the extension of filopodia 
and selectively EC activation, which are both observed when Notch or VEGF-A signaling are 
altered (Gerhardt et al. 2003; Hellström et al. 2007; Bentley et al. 2014). This sprouting process 
requires two components, guidance cues to direct sprout growth and coordinated cell 
movements.  
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The signaling and growth cues which direct migration function both locally and over long 
distances. The local growth factor environment surrounding the cell is influenced by secreted 
proteins by the EC; for example, Flt1 modulation of the VEGF-A gradient in the ECM directs 
sprouts to migrate away from the parent vessel (Chappell et al. 2009). Similar to neuronal 
migration, EC are predicted to use filopodia to sense directional migration along local and long 
distance cues within the targeted tissue (Kater & Rehder 1995). As they encounter these 
guidance factors, the sprouts either alter their directional migration to either persist or redirect 
the trajectory of the vessel. The EC within the sprout undergo collective cell migration and 
individual cells within the vessel change positions frequently as the sprout extends into the 
ECM along guidance cues (Arima et al. 2011; Jakobsson et al. 2010). Migration and EC 
movement within the sprout is facilitated by extended junctions at the sprout front (Pelton et al. 
2014), resulting in cells which move in parallel and providing a border that permits cell-cell 
communication and presumably coordinates EC activity. The ability of EC to communicate 
and migrate is dependent on multiple signaling pathways, including Notch and VEGF-A. 
Increased Notch signaling, through genetic deletion of Dll4, or loss of VEGF-A signaling, due 
to heterozygously deleted Flk1, reduces migratory potential; conversely, increasing VEGF-A 
signaling, through loss of Flt1, increases migratory potential (Jakobsson et al. 2010).  
Through a combination of these external cues and cell communications, the sprout migrates 
in a directional manner within the extracellular space.  From these data a picture of sprout 
migration emerges. The ECM and existing vessels contain factors to direct the nascent sprout, 
which is able to follow these sets of cues by continually extending sensory processes, 
appropriately the rearranging the cells, and migrating into the non-vascular areas of the 
network.  
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c. Anastomosis to create connections and new vessel conduits 
At the most basic level, anastomosis requires that two cells generate a new, stable, cell 
junction; appropriately, junction components have been the main consideration in anastomotic 
studies to date. Within the endothelial cells the creation of new junctions occurs in a 
stereotyped order. The order is as follows: first is homophilic binding of platelet endothelial 
cell adhesion molecule 1 (PECAM) on the surface of two EC; second is establishment of the 
adherens junctions (AJs), composed of multiple proteins including vascular endothelial 
cadherin (VE-Cad), β-catenin, p120, and plakoglobin; and finally the tight junctions (TJs), 
comprising proteins like zona occludins 1 (ZO1), claudins, nectins, and junctional adhesion 
molecules (JAMS) (Dejana 2004). The formation of each of these junctions is briefly discussed 
below. 
The reallocation of junctional proteins to generate new EC-EC connections is essential for 
anastomosis to occur. PECAM-PECAM homophilic binding is the first to occur, in part due to 
the non-restricted localization of the protein on the cell surface of EC (Feng et al. 2004). The 
ability of homophilic PECAM interactions to expand by diffusion-trapping on the cell surface 
and without a need for PECAM signaling (Sun et al. 2000; Privratsky et al. 2011) bolster the 
role of these junctional proteins in the first step of creating a new EC junction. These PECAM-
PECAM interactions provide a method for EC to identify like cells and begin the process of 
establishing more permanent junctions. After the EC initially bind, AJ proteins are recruited to 
the cell surface. Active trafficking of VE-Cad away from the cell-surface and into intracellular 
vesicles is accomplished through TSAd interactions with VEGFR2 downstream of VEGF-A 
ligand, such that VE-Cad is more present at junctions in EC with lower VEGF-A signaling 
(Esser et al. 1998; Gavard & Gutkind 2006). VE-Cad homophilic interactions anchor the 
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protein at the cell surface and set up the basis for AJ formation. Normal and full expression of 
VE-Cadherin is essential for new connections (Lenard et al. 2013; Montero-Balaguer et al. 
2009). The AJ components, including β-catenin and p120, are then actively recruited and 
maintained at EC junctions thus stabilizing the new EC-EC interaction through a positive 
feedback loop of AJ recruitment (Williams et al. 2000; Gaengel et al. 2012). Finally, stable 
scaffolding junctional proteins, namely ZO1, claudins and occludins, create TJs at the basal 
side of the junction. These junctions provide structural integrity to the cell in a tissue specific 
manner, for example the lung vessels have loosely organized TJs to allow exchange but the 
neurovascular interface has rigid and complex TJ (Gallicano et al. 2001; Saitou et al. 2000). 
All three types of junctions are detected between EC in established vessels, indicating their 
essential nature to blood vessels and linking their deposition at sites of connection to 
anastomosis.  
The components in EC that contribute to vessel anastomosis in embryonic zebrafish were 
recently explored. Two beds within the embryonic zebrafish have been examined during vessel 
fusion, the intersegmental vessels (ISVs) and the hindbrain (HB). Examination of the ISVs 
showed a stereotypic change in localization of the junctional proteins during anastomosis, 
including ZO1 and VE-Cad (Herwig et al. 2011). Genetic loss of VE-Cadherin results in 
connective failure in the HB vessels, and prevents the stereotypical rearrangements in EC 
junctions after initial connection that permits lumen ingression and flow after anastomosis 
(Lenard et al. 2013). Therefore, in order for anastomosis to proceed the formation of new 
junctions is needed. Additional work showed that blockade of filopodial extensions through 
pharmacologic inhibitors dampened, but did not abolish, anastomosis in multiple vessel beds 
(Phng et al. 2013). This indicates that filopodia may assist the formation of new connections 
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but are not an obligate component of anastomosis. Another non-obligate contributor was found 
in the F4/80+ macrophages in angiogenic retinal vessels of postnatal mice. F4/80+ 
macrophages were coincident with many sprout fronts and branch points, suggesting these cells 
support the vessel network, and potentially connections, during angiogenesis (Fantin et al. 
2010; Outtz et al. 2011).  
Combined, these studies suggest that the ability of vessels to form new, stable connections 
depends on creating new junctions and is assisted by non-EC support cells. However, a large 
number of questions remain from these data. For instance, whether new connections between 
EC are directed or stochastic, the signaling changes within sprouts and existing vessels as the 
two discrete EC form a new junction and which signaling components are most critical for 
permitting or blocking connections.  
As the physical aspects involved in the anastomosis have been described, at least in regards 
to the generation of new junctions, studying the regulatory and signaling events that direct 
these physical changes is a high priority. The signaling that directs endothelial cells during 
terminal guidance and anastomosis is a pressing question which is currently unaddressed by 
existing studies. The fluctuations between high Notch and high VEGF-A are conducive for 
coordinated migration of EC as a sprout but no information on how these signaling cascades 
influence and direct connections is available.  
d. Formation of a new lumen 
Having formed a new connection, the angiogenic vessel needs to transition into quiescence 
and rejoin the mature vasculature. In order for the newly formed vessel to contribute to the 
vessel bed, a continual luminal network is needed. The lumen is created at the apical side of 
EC and forms an open channel which carries blood and plasma through the network. The two 
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main processes thought to be critical to lumen formation are apical-basal polarity and blood 
flow.   
Apical-basal polarity is established within a cell to define a ‘top’ and ‘bottom’, 
respectively, in tissues that require this additional structural information for each cell, most 
notably in epithelium (Datta et al. 2011). This polarity is firmly established within vessels, 
such as the arterioles, and observed by unequal distribution of proteins like portioning 
defective homolog 3 (Par3), podocalyxin, and β1 integrin (Horvat et al. 1986; Iruela-Arispe & 
Davis 2009; Zovein et al. 2010). However, the distinct sidedness must be created or transferred 
when a new vessel is formed. These components are actively shuttled to and maintained at the 
appropriate domains of the cell surface by assistive proteins. Cell division control protein 42 
(Cdc42) and Ras-related C3 botulinum toxin substrate 1 (Rac1) are known to establish apical-
basal polarity in epithelial cells and are also required for EC to create lumens (Koh et al. 2008). 
Expression of podocalyxin (PODXL) and β1 integrin, the established markers in lumens for 
apical and basal polarity, respectively, can be found between the leading cells in a sprout 
(Horvat et al. 1986; Pelton et al. 2014), suggesting EC are primed for lumen formation early on 
during sprouting. The final stage of lumenization requires joining two formed lumens in 
relatively closely proximity. Recent work found that this joining is assisted by rearranging the 
cell morphologies through loosening junctions at the newly formed connection site and then 
the lumen expands using pressure from blood flow (Sauteur et al. 2014; Lenard et al. 2013). In 
fact, the EC membranes were observed to actively retreat through a mechanism termed inverse 
blebbing to permit luminal ingression (Gebala et al. 2016). This pressure driven rearrangement 
of cell boundaries is directly linked to blood flow at the apical surface of the newly connected 
vessels.  
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Once the new, continual lumen is formed, exchange of blood flow between the pre-existing 
vessels is found. At this point the vessels return to a quiescent state, and sprouting angiogenesis 
considered completed. 
 
 
IV. Perspective 
While data from our lab and others have explored the cues governing sprout initiation and 
extension along with lumen formation, relatively little is known about the signaling factors 
involved with terminal guidance leading to connection and fusion of a sprout with another vessel 
through anastomosis. Given previous data implicating VEGF-A signaling on a multitude of 
sprouting angiogenesis stages, a more in depth analysis of VEGF-A, Flt1 and anastomosis was 
undertaken using live imaging in a 3D in vitro angiogenesis model. The sprouting vessel and 
connecting vessel were examined prior to forming the new connection. In addition to classifying 
connective behaviors, we examined the impact of VEGF-A signaling through system wide and 
cell-autonomous manipulations of Flt1. Given the overall increase in vascularization of vessel 
beds with increased VEGF-A, we predicted that loss of Flt1 would increase VEGF-A signaling 
and thereby increase anastomosis. 
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CHAPTER 2: Materials and Methods
1
 
 
I. Experimental Materials and Methods  
a. Retinal Angiogenesis Imaging and Analysis 
Mice (Mus musculus) with flt-1
flox/flox
 alleles (Genentech; San Francisco, CA) were bred 
with [Tg(UBC-cre/ERT2), JAX #007001] mice that also carried the Cre-mediated 
recombination reporter gene R26R TdTomato [Gt(ROSA)26Sor
tm14(CAG-tdTomato)Hze
, JAX 
#007914]. Mice were maintained in accordance with the University of North Carolina, 
Chapel Hill Institutional Animal Care and Use Committee. Mosaic Cre excision of vessels 
was accomplished by IP injection of 0.5 mg/ml tamoxifen (MP Biomedicals; Santa Ana, CA) 
at P2. P5 retinas were perfusion fixed with 0.5% PFA/PBS, harvested, and fixed for 2h with 
2% PFA. Retinas were rinsed, counterstained for isolectinB4 and DAPI, and mounted using 
established protocols (Chappell et al. 2009). Images were acquired on a Leica DMI 6000B or 
Zeiss LSM 880 confocal microscope at 40× magnification, with optimal z-stacks compressed 
post-acquisition using ImageJ software. All antibody manufacturers and concentrations are 
listed in Table 2.1. 
Sprouts were identified in the angiogenic front using previously established methods 
(Chappell et al. 2009). Cellular genetic identity was classified from reporter expression 
during analysis and interactions between sprouts and other sprouts/vessels were identified as 
overlap of cellular extensions with other extensions/cells in the isolectinB4 channel. 
                                               
1
 Chapter 2 is adapted in part from Nesmith, J.E. et al. Blood Vessel Anastomosis is Spatially 
Regulated by Flt1 During Angiogenesis. Development, In review. (2016) 
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b. Cell Lines and Culture 
Human umbilical venous endothelial cells (HUVEC; Lonza, Portsmouth, NH) were 
maintained in EBM-2 media with the EGM Bullet Kit and 1X antibiotic/antimycotic (Sigma; 
St Louis MO) according to manufacturer’s directions. Normal human lung fibroblasts 
(NHLF; Lonza, Portsmouth, NH) were maintained in high-glucose DMEM supplemented 
with 10% FBS and 1X antibiotic/antimycotic. Mouse embryonic stem cells isolated from WT 
mice and flt-1
-/-
 mice (gift from G.H. Fong) were maintained and differentiated as previously 
described (Rylova et al. 2008).  
c. HUVEC Sprouting Angiogenesis Assay Imaging and Analysis 
The HUVEC sprouting angiogenesis assay was set up as described (Nakatsu & Hughes 
2008). Briefly, HUVEC were detached, combined with Cytodex microcarrier beads (Sigma; 
St Louis, MO), then incubated with periodic agitation for 4h. Following overnight growth, 
the HUVEC-coated microcarrier beads were embedded in a 1.5% fibrinogen-thrombin gel 
that was allowed to polymerize at 37°C for 15-45 min, and then a layer of normal lung 
fibroblasts were seeded on top of the solidified fibrinogen gel.  
Dynamic imaging of d3-5 HUVEC sprouts and vessels was performed on an Olympus 
VivaView Incubator Fluorescence inverted microscope at 10× magnification with image 
acquisition at 10 min intervals for 42h. Fixed imaging was performed at d5. After removing 
fibroblasts, cultures were fixed with 4% PFA for 15 min at RT. Cultures were permeabilized 
using 0.1% Triton-100 (Sigma; St Louis, MO) in Tris or Phosphate Buffered Saline (TBS 
and PBS, respectively) for 2-4h at RT and then blocked at 4°C overnight in TBS or PBS with 
0.1% Tween and 5% goat serum (blocking buffer). Primary antibodies were incubated as 
indicated in Table 2.1, washed with blocking buffer overnight and incubated overnight at 
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4°C with either goat anti-mouse conjugated secondary or goat anti-rabbit conjugated 
secondary in TBST or PBST (Life Technologies; Grand Island, NY). Confocal images were 
acquired on an Olympus FV1200 system using a 10× objective (NA 0.40) and optimal Z-
stacks, compressed post-acquisition for analysis. 
Vessel interactions were scored when two cell bodies overlapped in either the DIC or 
fluorescent channels, depending upon the experimental set-up. Interactions classified as 
transient contacts were defined as overlap in a single time frame, therefore lasting <10 
minutes. Stable connections were defined as overlap that persisted for >3 time frames, at 
least 20 min. Target vessel activity was classified as static or protrusive based upon the 
endothelial cells within 30 µm of the interaction site. Static vessels exhibited no LifeAct 
protrusions extending away from the vessel axis, while protrusive vessels contained a 
minimum of 3 extensions, defined as fluorescent protrusions >4 m. 
d. ES Cell-derived Vessel Imaging and Analysis 
Generation of ES cell lines expressing PECAM-eGFP was previously reported (Kearney 
2004). ES cell culture differentiation was performed as previously reported (Rylova et al. 
2008). Dynamic imaging of d7-8 differentiating ES cell cultures was performed as follows: 
confocal images at either 10× or 20× magnification using an Olympus FluoView FV1000 or 
FV10i system, both with full environmental chambers, were acquired at 4-10 min intervals 
for 16-20h. A z-stack, with 4-6 µm between focal planes, of 6-8 images was acquired at each 
time point. The z-stacks were compressed post-acquisition into a single image for each time 
point.  
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e. Zebrafish Experiments and Husbandry 
Zebrafish (Danio rerio) lines were carried on an AB strain background with transgenic 
insertion of either Tg(kdrl:eGFP) or Tg(kdrl:eGFP); Tg(hsp70l:vegfaa121;cmlc2:GFP) that 
were maintained as heterozygotes and genotyped through test crosses (Jin 2005; Wiley et al. 
2011). Heat shock inducible expression was activated in embryos 20 hpf by incubation for 30 
mins at 30°C. All zebrafish maintained in accordance with the University of North Carolina, 
Chapel Hill Institutional Animal Care and Use Committee.  
The Flt1 morpholino was previously designed, published, and verified for vessel defects 
and effectiveness (Krueger et al. 2011). Flt1 morpholino (3 ng) and control (PBS of 
equivalent volume) injections were performed on one-cell fertilized embryos. Genotyping of 
experimental embryos was identified using presence or absence of GFP expression in the 
cardiac muscle. Embryos were fixed at 48 hpf in 4% PFA for 15 mins for end point analysis. 
Imaging was performed on an Olympus FV1200 using 10× magnification and optimal z-
stacks, approximately 5 µm in width. Analysis was performed using Image J-Fiji software. 
All embryos with gross morphological defects were excluded from quantification. ISVs 
at the base of the yolk were imaged as described above. The confocal images were binned 
according to their connections along the DLAV. Those vessels which connected with a vessel 
not at the DLAV or formed multiple connection at the dorsal aspect were considered 
‘inappropriate’ or outside of the typical somite boundaries. 
f. Protein Quantification 
Protein analysis was performed on culture medium after concentration (Fisher Scientific; 
Pittsburgh, PA) or on cell lysates collected in Radiommunoprecipitation Assay (RIPA) 
Buffer + 1X protease inhibitor cocktail (Cell Signaling; Danvers, MA). Western blot analysis 
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was performed 48h after lentivirus infection or siRNA transfection. Briefly, protein 
concentration was quantified by the Bradford reaction (BioRad; Berkeley, CA) and 
equivalent protein amounts were loaded onto a 7.5% sodium dodecyl sulfate polyacrylamide 
gel for electrophoresis. Protein was transferred to a polyvinylidene fluoride (PVDF) 
membrane, stained with Ponceau S solution to visualize transferred protein and then 
incubated with the appropriate primary antibody in TBSor PBS with 0.5% Triton-100 
(Sigma; St Louis, MO). Horseradish peroxidase-conjugated secondary antibody was 
incubated with membranes for 1h at RT and chemiluminescent detection was performed. All 
antibody manufacturers, and concentrations are listed in Table 2.1. 
g. Lentivirus and siRNA knockdown 
The Flt1 shRNA construct (RHS3979-201732907; Dharmacon, Lafayette, CO) was 
modified to include GFP in addition to shFlt1. Lentivirus was produced by the UNC 
LentiCore Facility. Lentivirus was incubated with endothelial cells for 6-8h with addition of 
0.25 µg/mL of polybrene (EMD Millipore; Billerica, MA). Lentiviral infection with LifeAct-
GFP or LifeAct-RFP (gifts from Rusty Lansford [Addgene plasmid #51010] and Weiping 
Han [Addgene plasmid #64048], respectively) allowed visualization of F-actin.  
siRNA knockdown was performed by 6h incubation with RNAimax (Invitrogen; Grand 
Island, NY), and a pre-designed targeted construct against total Flt1 (Life Technologies; 
Grand Island, NY) or siRNA constructs, generated with locked nucleic acid (LNA) ends, 
targeting either the unique portions of sFlt1 or mFlt1 (Exiqon; Woburn, MA). Targeted 
sequences are listed in Table 2.2. Knockdown efficiency was quantified by Western blot. 
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h. Fluorescence-activated Cell Sorting (FACS) Analysis 
HUVEC were washed with PBS, detached using 1X accutase (Sigma; St. Louis, MO) and 
then fixed in FACS buffer containing 1% PFA. Cells were analyzed by flow cytometry using 
a BD Accuri
TM
 C6 flow cytometer and CFlow Plus Analysis software (BD Biosciences; San 
Jose, CA). Samples were manually gated and analyzed using the FloJo v10 software package. 
i. mRNA Preparation and Quantification 
RNA was collected 48h post-treatment using TRIzol® (Life Technologies; Grand Island, 
NY), according to the manufacturer’s protocol, and converted to cDNA using iScript 
(BioRad; Berkeley, CA), according to the manufacturer’s protocol. Quantitative real-time 
polymerase chain reaction (qRT-PCR) ΔΔCT analysis was performed on a 7900HT Fast 
Real-Time PCR system (Applied Biosystems; Grand Island, NY). Primers for Flt1 and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used to quantify mRNA. Primer 
sequences are listed in Table 2.3. Data are reported normalized to GAPDH.  
j. Statistical Analysis 
Statistical analyses were performed using GraphPad Prism® 6 software. A p value of 
<0.05 was considered statistically significant. The statistical methods and significance are 
noted in the Figure Legends. 
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II. Tables 
Table 2.1: Antibodies and Nuclear Stains.  
Primary 
Antibody 
Company CAT. # Use 
Western 
Blot 
Dilution 
Immunofluorescence 
Dilution/Time 
β-actin Cell Signaling 3700P HUVEC 1:10,000  
GFP Abcam ab6556 HUVEC 1:7,500  
Flt1 Abcam ab32152 HUVEC 1:2,000 1:1,000; 48h 
PECAM Cell Signaling 3528S HUVEC  1:1,500; 48h 
Conjugated 
phalloidin 
Life 
Technologies 
ab109202 HUVEC  1:50; 48h 
Alexa Flour® 
488 
Life 
Technologies 
A-21206 HUVEC  1:750; overnight 
Alexa Flour® 
555 
Life 
Technologies 
A-21428 HUVEC  1:750; overnight 
Alexa Flour® 
647 
Life 
Technologies 
A-21235 HUVEC  1:750; overnight 
DRAQ-7 Abcam ab109202 HUVEC  1:1000; 1h 
Isolectin 
conjugated 
Alexa488 
Life 
Technologies 
I21411 
Mouse 
retina 
 1:100; overnight 
DAPI 
Life 
Technologies 
D1306 
Mouse 
retina 
 1:1000; 30 mins 
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Table 2.2: siRNA sequences targeting Flt1 isoforms.  
Targeted Isoform Sequence (5’-3’) 
sFlt1 GAGCACTGCAACAAAAAGGCTGTTTTCTCTCGGATCTC 
mFlt1 GGAAATAGTGGGTTTACATAC 
  
 
36 
Table 2.3: qRT-PCR primers.  
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
GAPDH CCTCAAGATCATCAGCAATGCCTCCT TTGGTATCGTGGAAGGACTCATGACC 
Flt1 AGGGCCTCTGATGGTGATTGTTGA ATGCAGCACTACACATGGAGCCTA 
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CHAPTER 3: Blood Vessel Anastomosis is Spatially Regulated by Flt1 During 
Angiogenesis
2
 
 
I. Introduction 
As described in CHAPTER 1, blood vessel formation is an essential, conserved process in 
vertebrates that provides oxygen and nutrients to tissues and organs (Carmeliet 2005; Adams & 
Alitalo 2007; Chappell & Bautch 2010). Aberrant angiogenesis is associated with disease; for 
example, tumor angiogenesis is one of the hallmarks of cancer (Khurana 2005; Hanahan & 
Weinberg 2011). Blood vessel development during embryogenesis is a multistep process that 
begins with primitive vessel formation from endothelial progenitor cells through 
vasculogenesis (Risau & Flamme 1995; Drake & Fleming 2000; Xu & Cleaver 2011), and the 
subsequent formation of branched vessel networks is called sprouting angiogenesis. Sprouting 
angiogenesis is initiated by endothelial cells that proliferate, extend processes, migrate into 
extravascular space, and finally connect, or anastomose, with another vessel (Betz et al. 2016; 
Blanco & Gerhardt 2013; Larrivee et al. 2009). 
Among numerous regulatory signaling pathways, Vascular Endothelial Growth Factor-A 
(VEGF) signaling is required for sprouting angiogenesis (Shibuya 2013; Simons et al. 2016). 
VEGF binds to the endothelial cell-expressed receptor tyrosine kinases Flk1 (VEGFR2) and 
Flt1 (VEGFR1). VEGF-bound Flk1 triggers a signaling cascade that promotes endothelial cell 
proliferation, chemotaxis, and cell survival, thereby initiating and sustaining sprouting 
                                               
2
 Chapter 2 is adapted in part from Nesmith, J.E. et al. Blood Vessel Anastomosis is Spatially 
Regulated by Flt1 During Angiogenesis. Development, In review. (2016) 
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angiogenesis (Khurana 2005; Koch et al. 2011; Hanahan & Weinberg 2011). Flt1 is 
alternatively spliced to form two isoforms, a membrane-localized tyrosine kinase receptor 
(mFlt1) and a soluble isoform lacking the transmembrane and tyrosine kinase domains (sFlt1) 
(Kendall & Thomas 1993). Both isoforms of Flt1 have a 10-fold higher binding affinity for 
VEGF-A ligand than Flk1 and complete genetic deletion is embryonic lethal in mice (Kendall 
& Thomas 1993; Fong et al. 1995). Nonetheless, sFlt1 cannot independently signal, and mFlt1 
has weak kinase activity that is not required for developmental angiogenesis (Ito et al. 1998; 
Hiratsuka et al. 1998). Thus Flt1 functions as an endothelial cell-intrinsic decoy receptor or 
ligand sink to negatively modulate VEGF signaling amplitude during angiogenesis. 
Stages of sprouting angiogenesis include sprout initiation, extension, anastomosis, and 
lumenization (Chappell et al. 2011; Geudens & Gerhardt 2011). Sprout initiation, extension 
and lumen formation are relatively well understood processes. Recent zebrafish studies 
revealed a role for endothelial cell filopodia in vessel anastomosis, and found that adherens 
junction-mediated cell rearrangements subsequent to connection promote lumen formation 
(Lenard et al. 2013; Phng et al. 2013). However, it is unknown whether the site or timing of 
sprout anastomosis is regulated.  
We recently showed that Flt1 positively affects the stability of new conduits, suggesting 
that Flt1 may regulate aspects of anastomosis that affect stability (Chappell et al. 2016). Here 
we show that extending sprouts form transient contacts before establishing stable connections. 
Flt1 regulates the frequency of transient contacts and the probability of a target site being used 
for a permanent connection, and this spatial selectivity requires mFlt1. These results indicate 
that blood vessel anastomosis is temporally and spatially regulated by endothelial cell-intrinsic 
signaling. 
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II. Results 
a. Flt1 Influences Retinal Vessel Interactions  
Global or vascular-selective deletion of flt1 in mouse post-natal retinal vessels increased 
overall sprouting and filopodia (Chappell et al. 2009; Ho et al. 2012; Chappell et al, in prep). 
To better understand the role of negative modulation of VEGF-A signaling in sprout 
anastomosis, we used low-dose tamoxifen to induce mosaic excision of flt1 in retinal vessels, 
with an excision reporter (Fig 3.3.1).  
Sprouts were defined as previously described (Chappell et al. 2009) and interactions 
between vessels at the angiogenic front were identified (Fig 3.3.1A). The interacting 
endothelial cells were classified based on the cytoplasmic reporter expression in the endothelial 
cell from which filopodia extended (Fig 3.3.1B-C). Interestingly, wildtype (WT) sprouts were 
linked to flt1-/- endothelial cells significantly more often than to WT cells (Fig 3.3.1D), 
suggesting that Flt1 influences sprout connection parameters. However, further analysis of 
sprout anastomosis in mouse retinas was hampered by our inability to follow this dynamic 
process over extended time periods to determine what precedes and follows the static 
interactions. Moreover, most retinal interactions are at the front and consist of two sprouts 
intersecting, which does not allow for analysis of target site selectivity. 
b. Transient Contacts Precede Stable Blood Vessel Connections  
To better understand the dynamics of blood vessel anastomosis, we turned to primary 
human umbilical vein endothelial cells (HUVEC) in a 3D sprouting angiogenesis assay to 
model mammalian angiogenesis and anastomosis in vitro (Nakatsu & Hughes 2008). HUVEC 
coated onto beads and placed in a fibrin matrix form lumenized sprouts that often connect with 
 
41 
targets over 3-7 days. LifeAct-expressing HUVEC were imaged from days 3-5 (d3-5) of 
sprouting, allowing for visualization of F-actin in live cells and dynamic assessment of 
endothelial cell behaviors preceding and during anastomosis (Fig 3.3.2A, Movie 1). We were 
surprised to see two distinct forms of interaction between extending sprouts and potential 
targets in these movies. We scored brief, limited interactions (present for only one 10 min 
frame) of cytoplasmic extensions from the sprout that we termed transient contacts (Fig. 2A
i-
iv
). We also documented longer interactions, termed stable connections, which persisted for at 
least 30 minutes, and were often coincident with a widened sprout front and/or lumen 
formation (Fig 3.3.2A
v-viii
). Transient contacts occurred on average four times prior to a sprout 
forming a stable connection (Fig 3.3.2B). These transient contacts occurred throughout the 
lifetime of the sprout and at varying distances from the eventual connection site (Fig 3.3.2C).  
To further characterize the transient contacts that precede stable sprout connections, we 
quantified the LifeAct fluorescence intensity at transient contact locations prior to, during and 
subsequent to the transient contact (Fig 3.3.2D-E). Fluorescence intensity in the contact area 
was increased at the contact site compared to either side (Fig. 2D) and higher at the contact site 
during contact than at either pre-contact or post-contact times (Fig. 2E), confirming the 
transient nature of the contacts. Taken together, these results suggest that endothelial cell 
cytoplasmic extensions transiently “sample” potential target areas before forming a permanent 
connection.  
c. Flt1 Regulates the Number of Transient Contacts  
We next wanted to understand whether blood vessel anastomosis is a regulated or 
stochastic process, and we hypothesized that VEGF signaling regulates aspects of anastomosis. 
We manipulated VEGF signaling by reducing levels of a negative modulator, Flt1. We 
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generated and validated a lentivirus shRNA targeted against both isoforms of Flt1 (Fig S3.1A-
B) and showed a high infection efficiency by flow cytometry (Fig S3.1C). We used the 3D 
sprouting angiogenesis assay to examine the effects of Flt1 knockdown (KD) on branching and 
sprouting parameters, and found that sprouting from the bead was unaffected but branching 
was significantly increased with loss of Flt1 (Fig 3.3A-B). These results are similar to effects 
of Flt1 loss in postnatal retinas.  
We used time-lapse imaging in the sprouting angiogenesis assay to assess the effects of 
Flt1 manipulation on transient contacts and stable connections (Fig 3.3C-G, Movies 2-3). Both 
control and Flt1 KD sprouts had transient contacts and formed stable connections, but the 
dynamics were altered with reduced Flt1 levels. Connections from Flt1 KD sprouts formed 
earlier in the time sequence than controls, as measured from the emergence of a “tip-cell” 
phenotype (filopodia formation and directed migration away from parent vessel) to stable 
connection, although the overall distance travelled to the target was unaltered (Fig 3.3E-F). 
Consistent with the LifeAct analysis, control sprouts made about four transient contacts prior 
to forming a stable connection, but Flt1 KD sprouts averaged less than two transient contacts 
before forming a stable connection (Fig 3.3G). We also analyzed sprout behavior in mouse ES 
cell-derived vessels that differentiate over a week and form interconnected lumenized blood 
vessel networks (Rylova et al. 2008). ES cells transgenic for PECAM-eGFP and genetically 
deleted for flt1 (Chappell et al. 2009), also showed earlier connection times, similar connection 
distances, and reduced numbers of transient contacts prior to stable connection, relative to 
wild-type controls (Fig 3.3H-L, Movies 4-5). Taken together, these data suggest that sprout 
anastomosis is a regulated process, and that the number of transient contacts, which may be 
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exploratory behavior to gather information about potential targets, is reduced when Flt1 levels 
are reduced or absent. 
d. Differential Flt1 isoform Requirements for Sprout Anastomosis  
Flt1 regulates angiogenesis through both the membrane-bound decoy receptor and the 
secreted isoform that also acts as a ligand sink (Kendall & Thomas 1993; Roberts et al. 2004), 
so we examined the influence of each Flt1 isoform on sprout anastomosis. We generated and 
validated isoform-specific siRNAs that selectively reduced levels of mFlt1 in cell lysates or 
sFlt1 in conditioned medium (i.e. secreted sFlt1) (Fig 3.4A-C). In the sprouting angiogenesis 
assay, HUVEC sprouts with knockdown of total Flt1 via siRNA mimicked the effects of the 
shRNA knockdown, with no effect on sprouting from the bead but significantly increased 
branching (Fig 3.4D-E,H-I). Likewise, selective knockdown of either isoform did not affect 
sprouting, but knockdown of mFlt1 increased branching, while knockdown of sFlt1 did not 
affect branching in this assay (Fig 3.4F-I). We then used live-imaging to determine the number 
of transient contacts that occurred before stable connections formed, and found that 
knockdown of either Flt1 isoform reduced the number of transient contacts prior to stable 
connection (Fig 3.4J). These results suggest that, despite different ultimate effects on vessel 
morphology, both Flt1 isoforms are important in regulating the exploratory behavior of sprouts 
as they approach potential connection targets.  
We next examined target sites for transient contacts and stable connections, and asked 
whether target areas had unique attributes prior to contact or connection. We focused on targets 
that were part of established vessels or sprouts, as opposed to targets that were other tip cells, 
so that the incoming (i.e. non-target) sprout in principle had a choice of sites for formation of 
transient contacts or stable connections. Live-imaging of LifeAct-infected HUVEC in the 
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sprouting angiogenesis assay revealed that some endothelial cells in the target area exhibited 
protrusive activity, while others were non-protrusive, or static (Fig 3.5A-B). Analysis of time 
stamps just prior to transient contact or stable connection showed that subsequent transient 
contact sites were equally likely to be protrusive or static, but sites for stable connection were 
more likely to exhibit protrusive activity prior to connection (Fig 3.5C). Thus protrusive 
behavior correlates with target sites for stable connections, suggesting that this attribute 
contributes to spatial selectivity in anastomosis via differential cell behaviors prior to stable 
connection but not transient contacts, consistent with transient contacts being exploratory in 
nature.  
 Because protrusive activity is associated with endothelial cells that will subsequently 
form stable connections, and protrusive activity is associated with loss of Flt1 (Chappell et al. 
2016), we hypothesized that Flt1 levels within target endothelial cells would affect the 
probability of forming a stable connection. We first examined Flt1 expression at target sites. 
Flt1 levels are heterogeneous in developing blood vessels (Kappas et al. 2008; Chappell et al. 
2009), so we predicted that this heterogeneous expression would contribute to target site 
selection during sprout anastomosis. Fixed-image staining, using PECAM-1 to define cell 
borders and interactions, revealed that Flt1 intensity was decreased in target endothelial cells 
that were “touched” by sprouts (note that contacts vs. connections cannot be distinguished 
absent live-imaging) compared to neighboring cells (Fig 3.5D-E). Next we manipulated Flt1 
expression at the target site by generating mosaic HUVEC vessels that were a 50:50 mixture of 
endothelial cells with Flt1 KD (green) and control endothelial cells (red). These mosaic beads 
were incubated with control beads coated with unmanipulated endothelial cells without 
reporter expression (Fig S3.2A). We then live-imaged unmanipulated sprouts approaching 
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mosaic target areas to analyze their behavior. Controls where neither reporter was linked to 
Flt1 KD showed no bias in either transient contact or stable connection target site selection, 
relative to input or to each other (Fig S3.2B). In contrast, in experiments where both control 
and Flt1 KD endothelial cells were available as targets, there was a significant bias towards 
Flt1 KD endothelial cells as connection targets relative to contact (Fig 3.5F, Fig S3.2C).  
We then examined the role of each Flt1 isoform in the preference for endothelial cells with 
reduced Flt1 as stable connection sites. We live-imaged mosaic target vessels in which control 
endothelial cells were mixed with endothelial cells with knockdown of total Flt1, mFlt1 or 
sFlt1 via siRNA. Similar to total Flt1 knockdown by shRNA, siRNA Flt1 knockdown target 
endothelial cells were significantly more likely to form stable connections relative to transient 
contacts, and this bias was recapitulated by selective reduction of mFlt1 from endothelial cells, 
but not by selective reduction of sFlt1(Fig 3.5G-I). Taken together, these findings indicate that 
sprouts sample potential targets in an unbiased way via transient contacts, and form stable 
connections with target site selectivity influenced by relative mFlt1 levels.  
 
III. Perspective 
Here we highlight dynamic features of blood vessel sprout anastomosis, and show that 
connection site selectivity in developing vessel networks is regulated by levels of the VEGF 
receptor Flt1. Our results indicate that endothelial cell “sampling” occurs prior to formation of 
stable connections in expanding vessel networks where sprouts have “choices”. These brief 
interactions likely impart information to the sprout regarding the appropriateness of a given 
endothelial cell for stable connection. Initial analysis of mosaic retina vessels mosaic revealed 
that wildtype sprouts interacted more often with flt1-/- cells. This bias was also found in HUVEC 
mosaic vessel targets with reduced Flt1. Thus cells with reduced Flt1, and presumably 
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experiencing more VEGF signaling, are favored as sites of stable connection, and this bias 
depends on the expression of the membrane bound decoy VEGF receptor, mFlt1. 
In summary, this work shows that endothelial sprout anastomosis is a regulated process and 
implicates VEGF signaling in both the exploratory behavior that precedes formation of stable 
connections and connection target site choice. These findings suggest that the location and 
timing of establishing a stable connection is essential in forming a new conduit in vascular beds 
that do not have an imposed pre-pattern. This requirement for Flt1 in the regulated patterning of 
anastomoses suggests a novel role for the VEGF signaling pathway in blood vessel patterning, 
and potentially new ways to regulate vascular network formation with implications for 
regenerative medicine.  
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IV. Figures 
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Figure 3.1: Flt1 Influences Retinal Vessel Interactions In Vivo. 
 
(A) Vascular front of representative P5 retinal vessel with mosaic loss of Flt1. (A
i
) Merge 
visualized with excision reporter (A
ii
, red), vessels (A
iii
, green) and nuclei (nuclei, blue). Scale 
bar, 25 µm. (B-C) Higher magnification of left box (B) and right box (C) outlined with dashed 
lines in A. Arrow, scored interaction; white dotted lines, the area behind the extension used to 
define the category. (D) Quantification of mosaic interactions (n=7 retinas, 45 sprouts). 
Statistics, paired two-tailed Student’s t-test (**, p<0.01). Error bars, mean ± 95% CI. 
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Figure 3.2: Blood Vessel Stable Connections are Preceded by Transient Contacts.  
 
 (A) Live-imaging of HUVEC infected with LifeAct. Representative time-lapse stills of DIC 
(left) and fluorescence (right) channels over d3-5. (A
i
-A
iv
) Transient contact. Insets show scan 
area. Green arrowhead and dotted line, location of pre-contact scan; Red arrowhead and dotted 
line, location of transient contact scan; blue arrowhead and dotted line, location of post-contact 
scan. (A
v
-A
viii
) Stable connection. Orange arrow, example of stable connection. Scale bar, 25 
µm; time (lower left) hr:mins. (B-C) Quantification of transient contact frequency before stable 
connection (B), and relative time and distance from stable connection site at transient contact 
(C). n= 28 sprouts from 12 movies. (D) Fluorescence intensity of LifeAct at transient contact site 
was quantified across the site (dashed line in insets panel A) pre-contact (A
ii
, green line), at 
contact (Aiii, red line), and post-contact (A
iv
, blue line). (E) Fluorescence intensity of LifeAct at 
transient contact site was quantified pre-contact time (green arrowhead in A
ii
), at contact time 
(red arrowhead in A
iii
), and post-contact time (blue arrowhead in A
iv
). n=14 contacts from 9 
movies. Statistics, One-way ANOVA with Bonferroni’s post-hoc correction (*p<0.05, 
**p<0.01). Error bars, mean ± 95% CI. 
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Figure 3.3: Transient Contact Dynamics during Vessel Anastomosis are Regulated by Flt1.  
 
(A) Representative images of HUVEC sprouts with indicated treatments at 5d in 3D sprouting 
angiogenesis assay, stained with phalloidin and depth-encoded. Scale bar, 50 µm; EV, empty 
vector; shFlt1, lentivirus-expressing Flt1 shRNA. (B) Quantification of indicated parameters at 
5d (control, n=41 beads; shFlt1, n=41 beads). (C-D) Representative time-lapse stills of EV (C) 
and shFlt1 (D) HUVEC sprouts from 3-5d live-imaging. Transient contact, red arrowhead; stable 
connection, red arrow. Scale bar, 25 µm; time (upper right), hrs:mins. EV control (n=27 sprouts), 
shFlt1 (n=41 sprouts). (E-G) Quantification of indicated parameters. (H-I) Representative time-
lapse stills of WT (H) and flt1-/- (I) ES cell-derived vessels at 6d of differentiation. Transient 
contact, red arrowhead; stable connection, red arrow. Scale bar, 10 µm; time (upper right), 
hrs:mins. (J-L) Quantification of indicated parameters (WT, n=88 sprouts; flt1-/-, n=48 sprouts). 
Statistics, Two-tailed Student’s t-test (**, p<0.01; ***, p <001; ****, p<0.0001; NS, not 
significant). Error bars, mean ± 95% CI. 
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Figure 3.4: Both Flt1 Isoforms Reduce Transient Contacts Prior to Connection. 
 
(A) Schematic showing Flt1 isoforms and sequences targeted by indicated siRNAs. (B-C) 
Western blot of HUVEC lysates (B) and concentrated conditioned media (C) with indicated 
knockdowns. Fold change from control shown below lanes. (D-G) Representative HUVEC 
sprouts with indicated treatments, stained for phalloidin at 5d and depth-encoded. Control (n=15 
beads); total si-Flt1 (n=12 beads); si-sFlt1 (n=15 beads); si-mFlt1 (n=14 beads). Scale bar, 50 
µm. (H-I) Quantification of indicated parameters. Statistics, One-Way ANOVA with 
Bonferroni’s post-hoc correction (*p<0.05; **, p<0.01; ****, p<0.0001; NS, not significant). 
Error bars, mean ± 95% CI. 
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Figure 3.5: Target Vessel Connection Site is Biased by Flt1. 
 
(A-B) Representative images of LifeAct-infected 3D HUVEC sprouts and targets showing 
transient contacts. Green arrowheads, LifeAct-positive protrusions. Scale bar, 10 µm. (C) 
Quantification of target cell protrusions (see Methods for definition of “static” and “protrusive”) 
at time stamp immediately preceding contact (n=63 events) or connection (n=18 events). 
Statistics, Observed vs. Expected Binomial Test (**, p<0.01). (D) Left, Representative HUVEC 
vessel at 5d (with indicated staining). Middle and right, Flt1 channel only. Interacting target cell 
(red outline) and neighboring target cell (blue outline) of representative HUVEC vessels are 
noted. Scale bar, 25 µm. (E) Relative Flt1 staining intensity between pairs of endothelial cells 
was quantified (n=29 pairs). Statistics, Unpaired Student’s T-test versus no difference (red line) 
(*, p<0.05). (F) Representative time-lapse images from d3-5 of WT sprout (no label) and target 
vessel with 50% Flt1 KD endothelial cells (green) and 50% WT cells (magenta). Scale bar, 25 
µm; time (lower right), hrs:mins. Transient contact, red arrowhead; stable connection, red arrow. 
(G-I) Percentage of transient contacts and stable connections with endothelial cells of indicated 
type in mosaic target vessels (si-Flt1 vs. WT, n=41 contacts, n= 12 connections; si-mFlt1 vs. 
WT, n=57 contacts, n=17 connections; si-sFlt1 vs. WT, n=53 contacts, n=17 connections). 
Statistics, Observed vs. Expected Binomial Test (**, p<0.01; NS, not significant). 
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Supplementary Figure 3.1: Flt1 shRNA Validation. 
 
(A-C) HUVEC collected 48h post-infection with indicated lentivirus and analyzed by qRT-PCR 
(A), Western blot (B), or FACS sorted for infection efficiency (via GFP signal) (C). Flt1 mRNA 
expression was normalized to GAPDH and relative to control. Flt1 protein expression was 
normalized to β-actin and relative to EV-GFP. Statistics, Unpaired two-tailed Student’s t-test (*, 
p<0.05; ****, p<0.0001). Error bars, mean ± 95% CI. 
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Supplementary Figure 3.2: Transient Contacts and Stable Connections in Mosaic Target 
Vessels. 
 
(A) Schematic of experimental design for mosaic vessel live-imaging analysis. (B-C) Percentage 
of transient contacts and stable connections with WT sprouts and endothelial cells (EC) with 
indicated manipulations in mosaic target vessels. (EV-tdTomato vs. EV-GFP, n=19 contacts, n=8 
connections; shFlt1 vs. WT, n=95 contacts, n=36 connections). Statistics, Observed vs. Expected 
Binomial Test (***, p<0.001; NS, not significant). 
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CHAPTER 4: Flt1 During Sprouting Angiogenesis 
 These are preliminary data and an addendum to the completed story presented in the 
previous chapter. As such, the rationale and potential follow-up experiments are included within 
each section. 
 
I. Results 
a. Connection stability and success requires Flt1 
Previous studies of Flt1 and VEGF signaling during sprout initiation and extension 
demonstrated a strong requirement for the ligand and receptor in patterning the vasculature 
(Chappell et al. 2009; Kappas et al. 2008; Gerhardt et al. 2003). To understand how sprouts 
contribute to pattern in real time, we performed time-lapse imaging of flt1-/- ES cell-derived 
vessels alongside WT ES cell-derived vessels from the start of sprout initiation to completed 
anastomosis. These data allow understanding of connective success and the impact of VEGF 
signaling throughout angiogenesis. 
This analysis of ES cell-derived sprouts during sprouting angiogenesis identified and three 
distinct outcomes for a sprout: retraction, unmaintained connection, and maintained connection 
(Chappell et al. 2016). Unique in the outcomes, retracted sprouts do not form a connection 
within the vessel but instead rejoin the parent vessel from which they emerged. The other two 
outcomes form new conduits but over time exhibit different contributions to the network 
morphology. An unmaintained connection initially forms a new branch point but eventually 
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this new connection breaks down and merges with existing vessels, unlike maintained 
connections which form a new branch point and permanently expand the complexity of the 
vessel network. In WT ES cell-derived vessels, the sprouts were evenly split into thirds with 
37.5%, 33.1% and 29.4% of the sprouts resulting in retraction, unmaintained connections, and 
maintained connections, respectively (Fig 4.1A). In flt1-/- sprouts, the retractions decreased to 
12.6% and unmaintained connections increased to 48.6% (Fig 3.4.1A). The rate of maintained 
connections was not significantly altered (Fig 4.1A). Given the observed changes in outcome, 
we conclude that without Flt1 the sprouts which are unable to properly retract may compensate 
through an alternate method of failure.  
We then investigated the unmaintained connections further to understand the mechanism of 
increased connective failure in flt1-/- ES cell-derived vessel networks. The unmaintained 
connections in both genetic backgrounds collapsed into the parent vessel in two different 
fashions. We termed these active collapse and passive collapse, which were distinguished by 
the presence or absence of protrusive endothelial cells into the newly formed ‘gap area’ (Fig 
4.1B). If the gap area closed over time without any protrusions from the surrounding 
endothelial cells, this indicated a passive collapse but if the gap area is invaded by endothelial 
cell protrusions during collapse it was determined to be an active collapse (Fig 4.1B-C). WT 
ES cell-derived vessels showed predominantly passive collapse, at 66% of the time, while 
active collapse was more prevalent in flt1-/- ES cell-derived vessels, occurring 78.3% of the 
time (Fig 4.1D). In addition to a different method of collapse, the two genotypes exhibited 
different timing for collapse as well. Both active and passive collapsed vessels in WT ES cell-
derived networks collapsed at the same rate, while in flt1-/- ES cell-derived vessels the passive 
collapse was 2.0-fold slower than the active collapse (Fig 4.1E). These data suggest that 
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connections require active maintenance cues that are downstream of Flt1, likely through its 
role in restricting VEGF. 
In flt1-/- ES cell-derived vessels, previously demonstrated to exhibit increased pFlk1 
(Roberts et al. 2004; Kappas et al. 2008), a higher percentage of sprouts form connections and 
these connections are more likely to fail, collapsing into the existing vessels and not 
maintaining their own branch point. In fact, the EC in flt1-/- ES cell-derived vessels are overly 
active and show increased protrusive activities that are correlated with the collapse of vessels 
after connection. Computational modeling of pFlk1, indicative of active VEGF signaling, 
predicted that these protrusions result from inappropriately active VEGF (Chappell et al. 
2016). These data suggest that after connection Flt1 dampens protrusive activities through 
preventing pFlk1 activity. However, this has only been demonstrated in silico as testing the 
activity of Flk1 is technically challenging in fixed imaging and not currently feasible in real 
time. Recent advances in computational analysis of complex staining patterns used to decipher 
VE-Cad activity, which decipher VE-Cad changes between inactive vesicle localization and 
active cell surface localization, could be applied to pFlk1 in these vessels (Bentley et al. 2014). 
Using this type of post-hoc analysis would allow vessels stained for pFlk1 to be analyzed on a 
sliding scale for regions with higher and lower activity and attempt to corroborate the 
predictions from in silico modeling. These data can elucidate the mechanism by which Flt1 is 
able to alter behavior of vessels after connection. 
Beyond mechanism, the failure in connections could be due to inappropriate selection of a 
connection site or a result of continued VEGF signaling in the surrounding vessels. While 
genetic deletion of Flt1 in the ES cell-derived vessel model is very informative for 
understanding VEGF signaling in angiogenesis, any discrete roles for Flt1 in the separate 
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stages must be teased apart using an alternate method. In order to isolate these effects, 
spatiotemporal control of Flt1 deletion is needed. This can be accomplished using recently 
developed optogenetic techniques (Deisseroth 2011), which takes advantage of light-induction 
driven by microbial opsin linked to Cre-recombinase would allow targeted, cell-type specific 
deletion of Flt1 at varying stages of angiogenesis. These methods would allow a separate 
examination of Flt1 when the vessel is re-entering quiescence, necessary for a complete 
understanding of the receptor’s ability to promote connective stability and maintain branches 
within the vessel network. 
b. Flt1 isoforms differently affect mitosis and protein localization 
Full Flt1 deletion alters intra-cellular signaling and increases proliferation, migration, and 
survival, a VEGF GOF mimetic. This effect has been demonstrated in whole mouse models, 
mouse ES cell-derived in vitro models of angiogenesis, and biochemically (Fong et al. 1995; 
Ito et al. 1998; Kearney et al. 2002; Kearney 2004). The Flt1 isoforms have unique effects on 
angiogenesis, with sFlt1 influencing proliferation, overall branching and sprout initiation while 
mFlt1 is only reported to impact proliferation (Kappas et al. 2008; Chappell et al. 2009). How 
these isoforms are differentially controlled and utilized by the sprouting cells is an open 
question. To address this we took advantage of HUVEC sprouting vessels to study 
angiogenesis, and specifically proliferation after depletion of each Flt1 isoform.  
Despite the relatively common use for modeling angiogenesis, the proliferative rate within 
HUVEC sprouts is not well defined (Wiley et al. 2011; Pelton et al. 2014; Kushner et al. 2016). 
We wanted to confirm that the Flt1 isoforms are able to rescue the proliferative increase 
reported in mouse ES cell-derived vessels. As the cells in the sprouts are presumed to 
experience different signaling and external pressures than those coating the microcarrier beads, 
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we only analyzed HUVEC within sprouts and excluded those on the beads (Fig 4.2A). The 
mitotic index in controls was 1.2% (Fig 4.2B). siRNA knockdown of Flt increased the mitotic 
index to 2.1%, while each of the isoforms showed a reduced effect, a mitotic index of 1.8% for 
si-sFlt1 and 1.6% for si-mFlt1 (Fig 4.2B). These results show equivalent effects on mitosis 
from either isoform alone and a greater effect when both Flt1 isoforms are reduced. This 
supports a conserved role for the Flt1 isoforms in sprouting angiogenesis across mouse ES cell-
derived vessels and HUVEC vessels. 
Previously, the ability of Flt1 to influence sprout migration has been suggested to be a 
product of its spatial localization. Specifically, the basal secretion of sFlt1 is proposed to act as 
a spatial coordinating factor, restricting VEGF ligand availability and thereby directing sprout 
migration in the extracellular space (Chappell et al. 2009). This model was proposed based on 
studies of chimeric ES cell-derived blood vessels but whether the ligand is selectively secreted 
or localized has not been examined. The potential biased protein localization of the Flt1 
isoforms was examined using HUVEC vessels that were stained for Flt1. Individual cells along 
lumenized vessels were identified using nuclear markers and PECAM staining. The apical or 
basal side of the cell was defined as the innermost or outermost third of the cell width (Fig 
4.2C). In untransfected cells there is no observable bias in Flt1 staining for the apical or basal 
domains of the cell (Fig 4.2D). si-sFlt1 HUVEC within lumenized vessels show a trend of 
more basally localized Flt1 while si-mFlt1 HUVEC within lumenized vessels show a greater 
apical than basal localization (Fig 4.2D). These data indicate that, surprisingly counter to the 
predictions from the model, sFlt1 is more apically localized and mFlt1 is more basally 
localized. However, the data are consistent with the newly proposed role of mFlt1 in sprout 
connections which occur on the basal side of the cell. These data don’t elucidate the impact of 
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selective isoform localization in the HUVEC vessels, but they provide a model that can be used 
to further investigate any unique and overlapping roles of each Flt1 isoform. 
As the isoforms are differently localized, this may indicate unique roles that require 
receptor presence at the appropriate cell surface. The apical and basal domains of the EC 
interact with very different surroundings. Apically the cell is exposed to constant fluid flow of 
the blood passing through the lumen while basally there are stable, permanent interactions with 
associated cells like smooth muscle cells, macrophages, and pericytes (Adams & Alitalo 2007; 
Chappell & Bautch 2010). These disparate environments require unique cell structures and 
signaling. The different domain components have been well classified in stratified epithelium 
where there is a clearly defined apical and basal side to the cell, however the endothelium is 
not a stratified tissue and these domains are less well understood in this tissue.  
Previous data in the lab identified the apical restriction of PODXL and basal restriction of 
collagen IV out at the front of the sprout (Pelton et al. 2014). To more precisely identify apical 
and basal restriction of Flt1 protein, and specifically each isoform, co-localization with these 
known domain restricted proteins is needed. Co-staining for Flt1 and either PODXL or collagen 
IV within the HUVEC sprouts should be the first step in investigating the observed trends. Not 
only will this provide a quantifiable metric for membrane localization, but these proteins 
provide a more restrictive and defined apical and basal compartment. Given the current data, we 
predict stronger co-localization of sFlt1 with PODXL and stronger co-localization of mFlt1 and 
collagen IV.  
A recent study in the hindbrain of rats sought to identify the apical and basal specific 
effects of VEGF ligand. These data demonstrated that VEGF was able to induce permeability 
when presented basally and found abundant Flk1 protein on the basal side of the EC while Flt1 
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was more prominent apically (Hudson et al. 2014). These protein localizations were associated 
to the spatially restricted effects of the ligand, presuming that the VEGF ligand was likely 
present at both sides of the cells but receptor presence limited the activity. The apical 
localization doesn’t fit with our proposed model for sFlt1 secretion during sprouting, but is 
consistent with the identified trends for sFlt1 localization in HUVEC sprouts. However, these 
data are not isoform specific. Therefore, reciprocal experiments in mice using flt1-/- and 
isoform selective flt1 mutants are an interesting proposition. If the lack of flt1 contributes to the 
biased response to VEGF ligand, then the flt1-/- mice should not exhibit the same bias. The 
question would then be whether presence of only the sFlt1 isoform mimics the WT or flt1-/- 
endothelial cells.  
These preliminary data (Fig 3.4.2) open an area of research examining the intracellular 
localization and potential impact of this spatial restriction of Flt1. As a potent modulator of 
VEGF signaling, differential location for the receptor could alter our understanding of where the 
VEGF growth factor gradient exists and the impact on endothelial cells and angiogenesis. 
c. Flt1 and VEGF signaling influence anastomosis within zebrafish vessels 
While the data presented in CHAPTER 3 present a compelling case for Flt1 spatial 
regulation of connections, an in vivo model which permits live imaging would bolster the 
conclusions presented. The embryonic zebrafish provides an in vivo model that can be readily 
and easily live imaged during sprouting angiogenesis (Childs et al. 2002; Isogai et al. 2001; 
Lenard et al. 2015). The VEGF-dependent vessels which grow from the common artery, form 
the intersegmental vessels (ISVs), and eventually connect to generate the dorsal longitudinal 
anastomotic vessel (DLAV) are a prime candidate (Wiley et al. 2011; Ghaffari et al. 2015).   
 
70 
Perturbations to the VEGF pathway were accomplished two ways in the embryonic fish. 
First, Flt1 was depleted by injection of a morpholino (MO) from previous publication, blocking 
the ATG start site for protein translation and knocking down the protein (Krueger et al. 2011). 
The Flt1 MO causes some defects in ISV patterning (Fig 4.3A), but a non-significant change in 
the connections outside the somite boundary, as compared to wild-type embryos (Fig 4.3B). 
Second, VEGF expression was increased via a heat-shock through whole embryo inducible 
transgene which is capable of generating ectopic sprouting from the common artery (Wiley et 
al. 2011). Increased VEGF expression causes ectopic sprout formation in the ISVs. In addition 
to the excess sprouts, these sprouts also fail to follow the normal guidance cues to generate the 
DLAV and form inappropriate connections between the somite boundaries (Fig 4.3A). Unlike 
Flt1 depletion, disrupting VEGF ligand causes a significant 5.6-fold increase in the frequency 
of inappropriate connections (Fig 4.3B). Most interestingly, these two manipulations have an 
additive effect and result in an 11.8-fold increase in inappropriate connections (Fig 4.3B). 
Therefore, VEGF ligand guides sprout growth in the ISVs and Flt1 influences VEGF ligand 
effects in these vessels.   
Altering VEGF signaling through either method caused a disruption in sprouting, resulting 
in connections that form outside the normal somite boundaries. Given the strong guidance cues 
that are present within the somitic boundaries, it is unsurprising that without exogenous VEGF 
signaling the disruption of Flt1 had no noticeable effect. However, upon both increased VEGF 
signaling and depletion of Flt1 a dramatic increase in connections outside the somitic 
boundaries are found. While these data do not address whether Flt1 can function as a predictive 
marker of vessel interaction outcomes in vivo, they do support a conserved role for the receptor 
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in restricting anastomosis in a complex environment. These preliminary data have established 
one model for further investigation of anastomosis in vivo using zebrafish ISVs. 
Recent work by the Gerhardt group analyzed anastomoses in angiogenic vessels after 
blocking filopodial extensions, via pharmacological blockade of actin filaments. This treatment 
blunted sprouting angiogenesis and inhibited anastomosis in a bed-dependent fashion, namely 
the ISVs were able to eventually connect but the CVP was not, and concluded that filopodia 
were dispensable for anastomosis (Phng et al. 2013). Our data indicate that filopodia and cell 
protrusions are used to regulate and direct connections, therefore we postulate that while 
connections may form in the absence of filopodia that they are not appropriately regulated. 
These conclusions were based upon HUVEC sprouts and could be examined using LifeAct 
zebrafish lines. This line is amenable to live imaging and would enable analysis of 
anastomoses formed in a variety of angiogenic vessel beds. Additionally, this line can be 
crossed with VEGF over-expression or Flt1 MO to examine the effects of these signaling 
pathways on actin dynamics.  
The next step with the available tools is to perform live imaging on these fish after 
manipulating VEGF signaling with heat-shock overexpression and MO knockdown. Given the 
outcomes in vitro, we predict transient contact between the vessels prior to observing 
anastomoses. In addition, if increasing VEGF signaling reduces contacts, the fish with over-
expressed VEGF and Flt1 MO should exhibit reduced contacts. If this role for VEGF is 
conserved the next experiment to analyze is ISVs containing a mixture of ECs with and 
without Flt1 MO. Based upon the data in HUVEC sprouts, the EC with reduced Flt1 should be 
preferentially targeted for connections. The genetic tools for manipulations of Flt1 isoforms to 
distinguish between the tyrosine kinase versus ligand sink roles of the receptor are not yet 
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created in this system. Generating these deletions or mutants could be accomplished using 
CRISPR targeting to the shared or unique regions of the receptor (Hoshijima et al. 2016). The 
selective creation of InDels within mFlt1, the essential Flt1 isoform for restriction connections, 
could be accomplished and used to generate a new line. As mFlt1 is reportedly only essential in 
pathological angiogenesis (Hiratsuka et al. 1998; Hiratsuka et al. 2001), a true deletion mutant 
should be both fertile and viable. This fish would allow isolated analysis of mFlt1 during 
connection and could be combined with GOF VEGF using already existing lines if needed. 
This set of experiments would nicely demonstrate that the quantified role for Flt1 in vitro is 
utilized in cells that are experiencing the full complement of signaling from the surrounding 
tissue and blood flow.  
The zebrafish have been live imaged to generate a basic understanding of where and when 
anastomosis occurs but few mechanistic analyses exist to date. Given the many genetic and 
chemical manipulations to which zebrafish are amenable, there is a great variety of 
experimental avenues to pursue in understanding the signaling that regulates anastomosis.  
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II. Figures 
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Figure 4.1: Vessel connection outcomes in ES cell-derived sprouting angiogenesis is 
influenced by Flt1.  
 
 (A) Extended sprouts were grouped into three categories depending on their connective success, 
either retracted (no prolonged connection observed), unmaintained (stable connection observed 
which does not contribute a new branch over time), and maintained (stabled connection that 
provides a new branch). Quantification and comparison of the percent sprouts within each 
category in WT and flt1-/- ES cell-derived vessels. Statistics, Two-Way ANOVA with 
Bonferroni post-hoc correction (*p<0.05). (B) Representative time lapse of sprout connection 
(red arrow) that undergoes passive collapse, outlined with red dashed line. Scale bar, 50 µm. 
Time, hours:mins. (C) Representative time lapse of sprout connection (red arrow) that undergoes 
active collapse, outlined with red dotted line. Green arrows indicate the protrusive events which 
distinguish active collapse. Scale bar, 25 µm. Time, hours:mins. (D) Comparison collapse type in 
WT and flt1-/- ES cell-derived vessels. Statistics, Two-Way ANOVA with Bonferroni post-hoc 
correction (**p<0.01). (E) The time from connection to complete collapse in WT and flt1-/- ES 
cell-derived vessels was quantified. Statistics, One-Way ANOVA with Bonferroni post-hoc 
correction (**p<0.01). Error bars, ± 95% CI.  
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Figure 4.2: Isoform specific effects on sprouting human endothelial venous endothelial 
cells.  
 
(A) Sprout specific effects on mitosis were examined in fixed D5 sprouts. Representative sprouts 
stained with phospho-histone H3 (pH3, green), nuclear marker (DRAQ7, blue) and actin 
(phalloidin, red). Only pH3+ nuclei within sprouts, yellow arrow, not those on the microcarrier 
bead, yellow arrowhead, were considered in the mitotic index. Scale bar, 50 µm (B) The relative 
mitotic index of NT, si-Flt1, si-sFlt1, and si-mFlt1 sprouts were quantified. (C) Sprouts were 
stained for Flt1, PECAM and nuclei. Single HUVEC within lumenized vessels were divided into 
thirds along lumen axis (dashed lines). Scale bar, 10 µm. (D) Relative Flt1 protein within apical 
and basal domains in NT (n=12), si-sFlt1 (n=7), and si-mFlt1 (n=6) transfected HUVEC. All 
statistics, One-way ANOVA with Bonferri’s post-hoc correction (**p<0.01). Error bars, ± 95% 
CI.  
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Figure 4.3: Flt1 and VEGF influence connections in zebrafish intersegmental vessels. 
  
(A) 48 hpf fish with eGFP labeled vessels, both with and without excess VEGF ligand and with 
and without Flt1 MO. Depth encoded along z-axis to distinguish ISVs. Arrows indicate 
connections outside somite boundaries. Scale bar, 100 µm.  (B) Quantification of connections 
outside somite boundaries per tail under each condition. Statistics, One-Way ANOVA with 
Bonferroni post-hoc correction (* p<0.05; **p<0.01, *** p<0.001, ****p<0.0001). Error bars, ± 
95% CI. 
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CHAPTER 5: Conclusions and Future Directions 
 
I. Summary of Flt1 regulation of blood vessel anastomosis 
We undertook a thorough analysis of anastomosis using in vitro assays, focusing on 
endothelial specific signaling directing and during connection. While this level of understanding 
is largely known for the signaling and growth cues that direct sprout initiation and extension, the 
signaling pathways that direct anastomosis remain poorly understood.   
The first, and one of the more novel and interesting observations, was that not all vessel 
interactions resulted in connection. Previous reports in multiple angiogenic systems indicated 
that connection was the obligate outcome of vessels interacting (Blum et al. 2008; Fantin et al. 
2010; Lenard et al. 2013). Our data found transient contacts between vessels occur 80% more 
often than stable connections. This suggests quite the opposite that in fact forming a stable 
connection requires specific signaling. Therefore vessel interactions have two possible outcomes, 
a supported interaction or stable connection and unsupported interaction or transient contact (Fig 
5.1A). Given that the interaction outcomes have a non-random rate, with connections occurring 
significantly less frequently than contacts, we propose that transient contacts and stable 
connections form by a regulated process.  
Regulation of transient contacts is supported by their cellular composition. We found actin-
containing extensions, as observed through use of an actin reporter line, at the time and location 
of transient contacts; suggesting the presence of filopodia. Filopodia in sprouting angiogenesis 
are positively regulated by VEGF-A signaling and correlate with appropriate guidance and 
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extension (Gerhardt et al. 2003; Chappell et al. 2013). We therefore examined vessel interactions 
in vessels with decreased Flt1, the ligand sink receptor which normally limits VEGF-A ligand 
activity. Initially, we looked at the postnatal mouse retina, a well-established model for sprouting 
angiogenesis and noted that wildtype sprouts had a greater incidence of interaction with flt1-/- 
cells. These data suggested VEGF-A may regulate vessel interactions during anastomosis; 
however, the retinal model is not conducive to time lapse imaging. Therefore we turned to two 
discrete in vitro models of sprouting angiogenesis which permit time lapse imaging, transient 
contacts decreased with increased VEGF-A signaling. In fact, the decrease was to a nearly 
random rate, equal likelihood of connection or contact, suggesting a strong reliance on Flt1 for 
vessel interactions to result in transient contact.  
Having observed a reliance on Flt1 and alternate outcomes of vessel interactions, we next 
explored the individual Flt1 isoforms as they have demonstrated unique roles for proliferation 
and network morphology during vessel development (Kappas et al. 2008). We were able to 
selectively deplete each isoform in HUVEC using siRNA. These isoform selective knockdowns 
demonstrated a role during HUVEC sprouting angiogenesis but surprisingly, both were equally 
required for transient contacts prior to stable connection. This indicates that transient contacts are 
regulated by VEGF-A ligand and an increase in ligand availability prevents transient contacts. 
We hypothesized the reduced contact numbers was due to Flt1 biasing vessel interactions 
toward stable connection and away from transient contact. To test this, we generated vessels with 
either WT or Flt1 KD, distinguished by cytoplasmic fluorescence, and assayed the outcome of 
sprout interactions at these mosaic vessels. Depletion of both Flt1 isoforms, by either lentiviral 
shRNA or siRNA, resulted in EC that were more likely to result in stable connections and less 
likely to result in transient contacts. These data suggest that Flt1 does in fact influence vessel 
 
83 
interactions, although whether this is due to its role as a ligand sink or signaling receptor is 
unclear. To clarify this issue, we then generated mosaic vessels with a single isoform KD. In the 
isoform selective experiments, the si-sFlt1 cells did not exhibit a difference in interaction 
outcome however si-mFlt1 cells phenocopied the total Flt1 KD effect. Therefore, we conclude 
that mFlt1 is the isoform responsible for the bias in vessel interaction outcomes (Fig 5.1A).  
This is the first reported mFlt1 specific role in angiogenesis. In fact, all previous studies have 
suggested that mFlt1 is dispensable for sprouting angiogenesis though implicated in some 
pathological and gestational scenarios (Hiratsuka et al. 1998; Hiratsuka et al. 2001; Kappas et al. 
2008). Thus these data provide not only the first report of a selective process for connection 
during sprouting angiogenesis but also implicate VEGF-A/mFlt1 signaling as the regulatory 
pathway in this process. 
 
II. Future directions for investigating Flt1 regulation of anastomosis 
a. Mechanism of mFlt1 influence on vessel interaction outcome 
The data demonstrate that mFlt1 is the contributing isoform for determining the outcome of 
vessel interactions and that it acts as a predictive marker for stable connection versus transient 
contact. Previous research indicates that phosphorylation of mFlt1 occurs downstream of the 
placental growth factor (PlGF) not VEGF-A, and more importantly tyrosine signaling is not 
critical for angiogenesis (Hiratsuka et al. 1998). Therefore, while mFlt1 possesses the ability to 
sequester VEGF-A ligand and act as a tyrosine kinase receptor it has been largely dismissed in 
the context of angiogenesis (Fig 5.1B) (Nishi et al. 2008; Chappell et al. 2009; Hudson et al. 
2014).  
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As the first report of a unique role for mFlt1 in angiogenesis, the cellular mechanism 
surrounding this effect should be further explored. Given the known effects of mFlt1 it is more 
likely that the mFlt1 expression in a cell is indicative of a cell primed for connection. Control 
of the cellular levels of Flt1 is influenced by the activity of Flk1, which in its active state is 
phosphorylated to pFlk1 (Roberts et al. 2004). Of the multitude of intracellular changes 
downstream of pFlk1, there are two candidates that should be investigated first as promoting 
connection: increased filopodia and loosening of junctional complexes.  
We observed increased connections at cells with more filopodia and less mFlt1, thus 
linking the two cell profiles. Increasing VEGF-A within the neonatal mouse retina, through 
injection of Flt1 neutralizing antibody, genetic deletion of Flt1 or injection of VEGF-A ligand, 
leads to increased filopodia from sprouting vessels (Gerhardt et al. 2003; Ho et al. 2012; 
Chappell et al. 2013). Subsequent work in zebrafish vessels indicated that filopodia promote 
anastomosis (Phng et al. 2013). Epithelial cells in the early embryo must sheet of cells to 
protect the developing embryo and tissues. During epithelial cell interactions the existence of 
‘filopodial priming’ was postulated as a method to promote the formation of new junctions 
because filopodia extension was linked to the cadherin-dependent coordinated adherence of 
epithelial cells (Raich et al. 1999). Filopodial priming could be conserved in endothelial cells 
and promote the formation of a continual network by directing connections to sites containing 
filopodia, which would also be primed for the creation of a new junction.  
If filopodia are the responsible party in promoting connection, then altering actin dynamics 
in cells should mimic the observed effects from manipulating mFlt1. As simple removal of F 
actin or excessive actin polymerization dramatically impact a wide array of cell behaviors, this 
approach is unlikely to yield information about connection dynamics. A cleaner approach, 
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though more technically challenging, would be to take advantage of other methods. First, 
optogenetically engineered actin that could be forcibly activated (Taslimi et al. 2014), in a 
temporal fashion immediately prior to contact and connection, in mosaic vessels to present 
cells with excess filopodia. Based upon the current data, this would promote stable connections 
in these cells. Alternately, laser ablation of fluorescently tagged actin within the filopodia prior 
to contact and connection would prevent filopodia from contributing to the interaction 
outcome, likely preventing stable connections. Through either of these methods the actin 
dynamics would only be altered at the relevant time frame and allow other migratory aspects to 
function normally; thus any observed biases in outcome are associated solely with filopodia 
presence or absence.  
Second, active pFlk1 loosens existing EC-EC junctions by initiating a signaling cascade 
through Src and p21 activated kinase 1 (PAK1) to internalize VE-Cad (Gavard & Gutkind 
2006). As VE-Cad activity is regulated by its localization, the end result of this shuttling is to 
create a less attached and thereby more motile cell within the vessel (Bentley et al. 2014). The 
rearranging of VE-Cad to establish a new junction is a proven requirement for anastomosis in 
zebrafish vessels (Montero-Balaguer et al. 2009; Lenard et al. 2013). Therefore, cells with low 
mFlt1 and increased pFlk1 may have a greater pool of free VE-Cad that would be ready for 
reincorporation into a new EC-EC junction at a connection. To test whether VE-Cad 
availability is responsible for the observed bias in connection selectivity, direct analysis of the 
protein during contact and connection is needed. A LOF mutation in zebrafish VE-Cad was 
previously analyzed during anastomosis and resulted in connections that were weakened and 
malformed (Lenard et al. 2013). Mimicking this deletion in HUVEC or mouse ES cell-derived 
vessels would allow analysis of VE-Cad function in the context of selectivity during 
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connection. Supplying LOF VE-Cad in mosaic vessels would allow determination of whether 
this protein is able to induce a bias in connection sites, presumably decreasing the likelihood of 
connection.  
The increase in pFlk1 and resulting cellular changes are the likely explanation for how 
mFlt1 alters cellular mechanics to increase connection likelihood; however, if the proposed 
experiments do not identify a bias, which matches the cellular effects of increased VEGF-A 
signaling, there may be a signaling role for mFlt1 during connection. Should the formality of a 
signaling role need to be tested, inactivation of signaling can be accomplished by kinase-dead 
mutations or full deletion of this section, like the mouse mutant (Hiratsuka et al. 1998). These 
manipulations leave the VEGF-A ligand sequestration aspect of Flt1 intact, but prevent 
signaling through the tyrosine kinase receptor. The signaling cascade that is reportedly 
differentially activated by Flt1 but not Flk1 is AK-thymoma/protein kinase B (AKT) (Hudson 
et al. 2014). Assessing the activity of AKT within modified mFlt1 systems can validate the 
manipulations in this pathway as well. Once confirmed, this modified mFlt1 can then be tested 
for a role in transient contact frequency and its ability to induce connection between vessels.  
Low mFlt1 expression indicates cells with high pFlk1 that are more capable of creating a 
supported, stable connection due to changes in cell structure downstream of VEGF-A. These 
proposed experiments manipulating filamentous actin and VE-Cad separate VEGF-A signaling 
from the changes in cell structure to isolate the components that are used to identify a cell that 
is primed or appropriate for connection.  
b. mFlt1 regulation influence on non-endothelial anastomotic regulation 
Previous data in mouse retinas suggested that vessel branch points are supported by the 
presence of tissue macrophages (Fantin et al. 2010). These are the only support cells proposed 
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to impact network formation at the level of connection and potentially discrete from sprouting. 
Further examination of this macrophage population failed to identify which receptors were 
responsible for the presence at branches. As a secreted ligand, VEGF-A is available to any 
cells that express the appropriate receptors and besides endothelial cells these comprise 
neurons and the hematopoietic lineage, including macrophages (Koch et al. 2011). 
Additionally, Flt1 is reported to recruit macrophages in a manner dependent on its intracellular 
signaling, a process which is defective in mice where the bone marrow is replaced with Flt1 
kinase-dead marrow (Murakami et al. 2008). Combining this knowledge with our new 
understanding of anastomotic regulation confounds our understanding of how the macrophages 
at branch points are recruited. If mFlt1 is reduced in target vessels at the sites of new conduits 
then the macrophages are not recruited to these points by straightforward Flt1 signaling. Two 
distinct possibilities resolve the macrophage recruitment signaling conflict, 1) mFlt1 recruits 
macrophages to the sprout but not the target or 2) site an alternate signaling mechanism recruits 
F4/80+ macrophages to sites of new connection.  
The experiments performed and analyzed in CHAPTER 3, focus on the signaling impact 
that the targeted vessel has on directing connection sites. As such, the observed bias that 
influences connection sites in the target vessel may not be the same bias that is used by 
sprouting EC to direct connection. As both sides of the connection are potentially able to 
contribute to selectivity, additional experiments to assess this potential are needed. Rather than 
mixing control sprouts with mosaic target vessels, sprouts containing KD of either complete or 
isoform selective Flt1 KD will be used. This will address whether Flt1 within the sprout is used 
in the identification of connection sites in the target vessel. The evaluated bias for transient 
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contact and stable connection will determine if these manipulations impact the regulation of 
vessel anastomosis. 
There are two candidate pathways for macrophage recruitment during anastomosis. First, 
Notch1 is reported to both recruit macrophages to vessels and activated at branch points during 
retinal angiogenesis in mice (Outtz et al. 2011). As high Notch1 signal is coincident with high 
Flt1 in EC, this is a prime candidate for the signaling, which recruits and educates 
macrophages at sites of connection. While full over-expression of Notch1 does not support 
sprouting angiogenesis (Larrivee et al. 2012; Chappell et al. 2013), a mosaic culture system in 
vivo using zebrafish could be used to address whether this signaling recruits macrophages to 
connections. Additionally, the myeloid lineage is reportedly recruited to angiogenic vessels by 
non-canonical Wnt signaling (Stefater et al. 2011). Intriguingly, the Wingless-related 
integration site (Wnt) signaling is a positive recruiter and is actively suppressed by Flt1 
expression. Again, this association fits with the association between low mFlt1 and connection 
sites. Should the Notch signaling not be implicated, this is the next candidate for investigation. 
The sequences for the various Wnt players, notably the homologues to Wnt5a and Wnt11 
which were previously implicated, are mapped in the zebrafish (Heisenberg et al. 2000; Huang 
et al. 2011). Examining the role of these signaling pathways in zebrafish will take advantage of 
the macrophage reporter line and previously identified anastomotic pathways (Fantin et al. 
2010). Combining the reporter lines for vessels and macrophages with knockdown of each Wnt 
candidate and heatshock over-expression of Notch1 will permit analyses of macrophage 
presence at the site of blood vessel anastomosis. 
These experiments, combined with further analysis of zebrafish vessel anastomosis, should 
generate a complete picture of the various components that are implicated in connection. The 
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data should link the EC signaling that is newly demonstrated to direct connections and the 
supportive or directive role of macrophages. 
c. Applications for anastomotic regulation in disease states 
Failure of the vascular and circulatory system is implicated in a host of diseases, including 
macular degeneration, heart failure, pathogenesis and recovery from stroke and ischemia, and 
solid tumor growth and metastasis (Carmeliet 2005). Of these, Flt1 has been implicated in 
stroke incidence and solid tumor growth and pathogenesis. Alterations in Flt1 levels result in 
de-regulated VEGF-A signaling, which leads to aberrant vessel growth. Misregulated blood 
vessel growth is strongly implicated in the pathogenesis and the development of tumor blood 
vessels has been identified as one of the hallmarks of cancer (Khurana et al. 2005; Hanahan & 
Weinberg 2011). Meta-analysis of multiple cancer types found that expression of PlGF in solid 
tumors caused overall patient survival to decrease 1.69 fold (Meng et al. 2015). As Flt1 is the 
activating receptor for PlGF in the endothelium, involvement of Flt1 in progression of these 
cancers is presumed. In fact, when PlGF-expressing tumor cells are injected into mice, strong 
tumor-directed angiogenesis is observed that is decreased upon deletion of Flt1 (Hiratsuka et 
al. 2001). As this ligand-receptor binding interaction involves the mFlt1 isoform over the sFlt1 
isoform, the recent data gains greater implications. We demonstrate that mFlt1 receptor 
presence dictates the involvement of a given cell in forming new conduits. This suggests 
potential therapeutic advantages for targeting the PlGF/mFlt1 axis of signaling in pathological 
angiogenesis. As the signaling contribution of Flt1 is limited and non-essential during 
developmental angiogenesis (Hiratsuka et al. 1998), is highly selective and based upon my data 
could dramatically impact the formation of new conduits. 
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The classic pathological condition in which anastomosis is considered are the collateral 
vessels. These vessels are unused conduits that only carry flow when the preferential route is 
occluded, through a plaque, ischemia, or experimentally using ligations. Many are thought to 
form at birth, but there is debate regarding whether new collaterals are generated in response to 
ischemic stress. The small diameter and number of these collaterals is correlated with survival 
after ischemia or cardiac events (Seiler et al. 2013). Collateral vessels are believed to be 
established early in development and manipulations in Notch1/Dll4 alter the density of pial 
collaterals (Cristofaro et al. 2013). As Notch signaling is strongly connected to VEGF-A 
signaling in the endothelium, consideration should be given to the impact of Flt1 on collateral 
vessels, especially given the new information regarding the impact of Flt1 on directing 
connections in blood vessels. To being with, investigation and quantification of the collaterals 
in mouse vessels with flt1-/-  and those with the tyrosine dead mutant, flt1Δ/Δ, are needed. 
Given the available in vitro data there should be a notable increase in the collateral vessels 
when Flt1 is decreased that may also be true in the kinase-dead mutant. Should a difference 
exist, further testing of the response of these mice to further ischemic challenges, such as 
surgical ligation, would determine if the altered collateral state has pathological implications.  
As stroke and solid cancers present a large public health concern, understanding the role of 
Flt1 as an anastomotic regulatory component is of interest. These avenues of research would tie 
the novel observations found here with clear clinical directions and therapeutic targets. 
 
III. Perspective 
Despite the breadth of knowledge on VEGF-A ligand and its receptors, the known 
therapeutics demonstrate limited efficacy in solid tumors (Weis & Cheresh 2011). As 
exemplified here, there are still undiscovered roles for VEGF-A signaling in regulated 
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angiogenesis. VEGF-A signaling has been clearly shown to regulate the initiation of both 
vasculogenesis and angiogenesis (Carmeliet et al. 1996; Shalaby et al. 1997), however a role in 
anastomosis was previously unreported. The implications of varied responses depending upon 
the angiogenic stage of the vessels may help to explain, the incomplete treatment responses. 
Identifying temporal cues that govern the varying stages of angiogenesis may allow selective and 
specific targeting of inappropriate angiogenesis. 
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IV. Figures 
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Figure 5.1: Schematic of mFlt1 regulation during blood vessel anastomosis.  
  
 (A) Schematic of vessel interactions that result in transient contact, which are not correlated 
with low mFlt1, and stable connection, which are correlated with low mFlt1. (B) The potential 
signaling roles of mFlt1 during connection. mFlt1 is known to act as a ligand sink to block 
VEGF-A binding to Flk1. Alternately, Flt1 preferentially activates intracellular signaling in some 
published reports, and therefore could be directly signaling for cellular changes which prohibit 
stable connections. Legends are included within each schematic.  
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